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1. Inflammation 
For centuries humans have intuitively identified inflammation with fire as a result of the 
experience of redness, heat, and pain associated with its occurence. Interestingly, scientific 
investigation of inflammation has extended this analogy. At the microscopic level, 
inflammation is described as an accumulation of leukocytes that “spread” within tissues and 
then ultimately “burn out” and heal or lead to “smoldering” conditions. Similarly, at the 
molecular level, leukocytes use an oxidative mechanism, in essence a form of biologic fire, 
that destroys microorganisms and damages tissues. Despite the essential truth of our 
intuitive sense of inflammation, the objective understanding has come slowly. 
While earlier advances were made with regard to manipulating humoral immunity as in 
the development of vaccines, in recent decades the focus of investigation has shifted 
towards revealing the “molecular language” that dictates the observed events and 
determines the quality, intensity, and duration of inflammation. The complexity of the 
immunoinflammatory system which utilises this language consisting of both humoral and 
cellular signals is a reflection of millions of years of environmental challenges. 
Inflammation is a defense reaction of living tissue to injury and infection. As such, the 
primary objectives of any inflammatory process are localization (in order to contain the 
potentially injurious reaction, e.g. tuberculous granulomas) and elimination of the foreign 
agent. Consecutively, a period of repair of damaged tissue is promoted. 
Traditionally, inflammation is classified in the terms of the clinical onset and duration of 
the response. Specifically, responses are acute when signs or symptoms occur within 
minutes to hours, subacute when the duration is days to weeks, and chronic if lasting weeks 
to months or even longer.  
 
 
1.1. Acute responses 
The earliest and simplest host response to irritation or infection is the transudate, a 
movement of fluid of low protein content from the intra- to the extravascular space. This 
reaction principally results from hemodynamic forces and is an attempt by the host to dilute 
the insulting agent. As vascular leakage increases with ongoing damage, the protein content 
of the fluid increases and will contain most plasma proteins as well as some cellular 
elements. At this point the fluid is an exsudate and contains “neutralizing factors”, such as 
clotting factors, antibodies, and protease inhibitors.  
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Under most circumstances the fluid exsudative stage is naturally followed by the influx 
of polymorphonuclear neutrophilic leukocytes (PML). These cells begin to appear within 
hours and, depending on the nature of the inciting agent, can accumulate in massive 
numbers. These end-stage phagocytic cells have profound microbial killing capacity 
through oxidative mechanisms, which is subsequently discussed. In addition, their 
lysosomes harbour a variety of proteolytic enzymes that digest tissue components and 
microbes when released from activated or dying cells. 
 
 
1.2. Chronic responses 
1.2.1. Macrophage-rich responses 
The macrophage or mononuclear phagocyte is a highly sophisticated cell which 
participates in many aspects of inflammation ( section 1.3.2.). It is capable of 
synthesizing and secreting a variety of cytokines depending on its state of differentiation. 
Histologically macrophages usually occur mixed with a variety of other leukocytes. Large 
numbers of them can be found in chronic pneumonitis, pleuritis, or peritonitis, as well as in 
lymph nodes draining sites of surgical implants or foreign bodies. Furthermore, they form 
foamy clusters in atherosclerotic plaques. 
 
1.2.2. Eosinophil-rich responses 
Eosinophils occur as a minor cellular component in several inflammatory responses, but 
under some conditions they dominate. Specifically, their association with certain parasitic 
infestations (particularly helminths) and allergic conditions such as allergen-associated 
asthma is well known. The mechanisms of eosinophil recruitment and activation are just 
beginning to be elucidated. Some carcinomas, particularly of the urinary tract, produce 
cytokines that recruit eosinophils to the stroma of the tumor. 
 
1.2.3. Plasma cell and lymphocyte-rich responses 
The lymphocyte and plasma cell-rich (lymphoplasmocytic) infiltrate is a commonly 
observed inflammatory pattern, especially at subepithelial sites. Lymphoid cells are major 
components of delayed-type hypersensitivity reactions and in tissue responses to viral 
infections. Interestingly, in some neoplasms, especially carcinomas and melanomas, an 
associated stromal lymphoplasmocytic response may indicate a better prognosis.   
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1.2.4. Mixed-cell responses 
Chronic inflammatory responses most commonly involve a variety of leukocyte types as 
well as proliferation of local tissue elements. The mixed type of inflammation accompanies 
many conditions at many sites. Chronic ulcerative colitis is a notable example of this 
heterogenous pattern of inflammation in which there is ongoing acute cryptitis with 
neutrophil infiltration and an interstitial lymphoplasmocytic infiltrate admixed with varying 
numbers of mononuclear phagocytes and eosinophils. Ulcer sites often show repair and 
regenerative changes with proliferation of fibroblasts, vessel components, and epithelium. It 
is not difficult to imagine the complexity of events that must occur to coordinate the 
recruitment and function of so many cell types. 
 
 
1.3. Humoral and cellular participants of inflammation 
Understanding inflammation requires a knowledge of the various components of the 
process. However, a detailed discussion of all the participating components is beyond the 
scope of this introduction which shall focus on cytokines and chemokines. Table 1 gives a 
brief overview over the other components. 
 
Table 1 
Participants of Inflammation   
Humoral elements  Coagulation and fibrinolytic factors, kinins, complement 
factors, immunoglobulins 
Blood-borne cells  Neutrophils  ( below), monocytes and mononuclear 
phagocytes ( below), eosinophils, basophils and mast 
cells, platelets 
Stromal  elements  Endothelial and epithelial cells, fibroblasts, smooth 
muscle cells, matrix proteins 
  
 
1.3.1. Neutrophils 
PMLs are the primary phagocytic cells involved in host resistance to bacterial infection. 
They represent the largest population (40 – 60%) of blood leukocytes and circulate for 
about 10 hours after release from the bone marrow. Under steady state conditions about  
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55% of the released cells are marginated by loose attachment to the endothelium. During 
maturation they develop cytoplasmic granules that contain a variety of molecules with 
antimicrobial activities ( sections 2. and 3.). Because of the activity of these degradative 
enzymes and oxygen metabolites, PML-rich responses are usually associated with 
significant bystander damage of host tissues.  
 
Fig. 1. Leukocyte-endothelial adherence during inflammatory responses. A: Stages of leukocyte 
adherence and aggregation. B: Photomicrograph showing leukocyte adherence and transmigration 
in an area of inflammation. [1]  
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Through a wide variety of membrane receptors, PML function can be regulated. E. g., 
receptors for complement fragment C3b and the immunoglobulin Fc region allow for more 
efficient phagocytosis of particles coated with these molecules. Receptors (integrins) for 
endothelial cell membrane proteins (addressins) and interstitial matrix proteins allow for 
local adherence of PMLs to sites of inflammation. Other receptors for chemotactic 
molecules (e.g. C5a and IL-8) and cytokines lead to PML activation and directed migration. 
Products of PMLs can also amplify inflammatory responses and regulate the activity of 
other cells. For example, granule plasminogen activator and membrane phospholipases 
promote vascular permeability and chemotaxis by respectively generating fibrin split 
products and metabolites of arachidonic acid. PML also actively synthesize and release 
cytokines with local and systemic effects.  
 
1.3.2. Monocytes and mononuclear phagocytes 
Monocytes and mononuclear phagocytes (M), also known as macrophages or 
histiocytes, are distributed throughout virtually all tissues. They are released into the 
circulation as monocytes, where they remain for about 25 hours. As with the PML there is a  
 
 
Fig. 2. Stages of phagocytosis of opsonized particle. Adherence is followed by engulfment and 
secretion. The biochemical reactions in the boxed area of the secretory cell are illustrated at lower 
right. [1]  
7  
 
large marginated pool. The monocytes then migrate to the tissues and become part of the 
tissue (fixed) macrophage population. These are found in high concentrations in the 
vasculature of the liver, spleen, and lungs where they remove effete cells and foreign bodies 
from the blood. Tissue macrophages also assist the regulation of immune responses and 
hematopoiesis. 
Unlike PML, M live longer and are capable of synthesizing a vast repertoire of 
bioactive products ( table 2). They also display a unique capacity to adapt to varied 
environmental challenges, a characteristic that is often enhanced and directed by signals 
provided by reactive lymphocytes as well as by humoral and bacterial products. 
M occur in varying numbers in nearly all forms of inflammation and likely participate 
in every stage of the inflammatory process. Local tissue macrophages can potentially 
initiate inflammation by producing cytokines in response to bacterial products such as 
endotoxin (lipopolysaccharides, LPS). Cytokines such as M-derived IL-1 and TNF can 
induce expression of endothelial adhesion molecules, which begin local recruitment of 
circulating leukocytes. Other chemotactic molecules such as IL-8 and leukotriene B4 can 
further attract inflammatory cells. 
Another major function of the M is phagocytosis, requiring the stages of attachment, 
engulfment, and destruction of the offending agent ( fig. 2). Although M bear receptors 
for carbohydrates that allow for nonspecific attachment to target particles, the attachment 
and engulment process is greatly enhanced when the object is coated with activated 
complement fragments or immunoglobulins (opsonization). The destruction stage consists 
in fusion of the phagosome and lysosome, with release of attacking enzymes and reactive 
oxygen metabolites. This process is enhanced when the M is activated. Activation is 
defined in terms of amplified functions, as compared to the initial baseline value, and 
occurs when the M is exposed to molecular signals such as IFN-, LPS, and MCP-1. The 
activated state can vary, depending on the signal, but involves increased synthesis of 
enzymes, membrane receptors, and cytokines. 
An important function of the activated M is antigen processing and presentation. After 
phagocytosis, foreign proteins are degraded into peptides and transported to the membrane 
in association with MHC class II antigens. The membrane-exposed complex of foreign and 
MHC antigens serves to activate antigen-specific helper (CD4
+) T-lymphocytes.  
  
8  
Table 2 [1] 
Products of M   
Plasma regulated proteins  Coagulation factors, complement components, haptoglobin 
Cytokines and growth factors  IL-1, IL-6, IL-1 receptor antagonist, TNF-, chemokines 
(IL-8, MCP-1, IP-10), growth- and colony stimulating 
factors (TGF-, PDGF, G-CSF, GM-CSF, EPO, FGF)  
Oxygen metabolites  O2
-, H2O2, OH
 
Active lipid products  Prostaglandins, prostacyclin, leukotrienes, PAF 
Matrix proteins    Fibronectin, proteoglycans 
Enzymes  Proteases, collagenases, elastase, plasminogen activator, 
angiotensin convertase, phospholipase A2, nucleases, 
lysozyme, hyaluronidase, amylase 
Enzyme inhibitors  A2-Macroglobulin, A1-Antiprotease, fibrinolysis inhibitors 
Other active molecules  Vitamin D3, glutathione, nucleic acid derivates 
 
 
 
1.4. Th1- and Th2-Responses 
As mentioned above, CD4
+ T-helper (Th) cells become activated when they are exposed 
to a complex of antigen and MHC class II molecules. However, it has become apparent that 
there are differences in the way these cells respond once they have been activated.  
If the activated Th-cell encounters IL-12, IL-15, and/or IL-18 that have been produced 
by other activated cells, the production and secretion of IL-2 and IFN- is induced. This set 
of cytokines acts on neighboring M and other phagocytic cells, triggering activation of 
intracellular enzyme systems that are effective in killing intracellular microorganisms such 
as Mycobacterium species or viruses. Such cells belong to the CD4
+ subset known as Th1 
cells. 
If, on the other hand, the activated T-cells produce and secrete a different set of 
cytokines, namely IL-4, IL-10, and IL-13, which inhibit M activation and instead 
stimulate B-lymphocytes to produce antibodies, this type of cells is referred to as Th2-cells. 
They mediate the release of eosinophils from the bone marrow and, among other functions, 
play an important role in infestations with extracellular parasites.   
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Fig. 3. The polarization of Th1 and Th2 responses by CD4+ Th cells and the role of the anti-
inflammatory cytokines in T-cell differentiation. Solid lines indicate stimulatory pathways, dotted 
lines indicate inhibitory pathways. APC: antigen-presenting cell; Th0: uncommitted CD4+ Th cell 
precursor. [2] 
 
 
2. Cytokines and Chemokines 
As mentioned above, communication between cells is crucial, especially in the immune 
system where reactions to stimuli or insults like stress, infectious organisms, or dysplasia 
have to be intricately regulated. This is accomplished by the synthesis and release of a huge 
family of proteins, the cytokines, as well as by the expression and integration of their 
respective receptors into the plasma membrane of all kinds of body cells. 
Cytokines are proteins with the capacity to alter target cell functions in an autocrine, 
paracrine, or endocrine manner. They particularly modulate cellular parameters related to 
immune defense reactions associated with infection, inflammation, or cancer and can be 
distinguished from other cellular products which also fit this definition. These include 
lipids, vasoactive amines, neuropeptides, nucleotides, and even metabolites of oxygen and 
nitrogen, and are termed mediators. Refer to section 2.2. for a more detailed discussion of 
selected cytokines.  
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A large number of cytokines has been identified and characterized, and although new 
ones are being discovered at a breathtaking pace, we are still far from a comprehensive 
understanding of this incredibly com-
plicated system. Nonetheless,  Figs. 4 [2]  
and 5 attempt a brief overview. Fig. 4 
positions some important cytokines 
alongside their cells of origin and targets, 
Fig. 5 relates them to the stages of 
immunoinflammatory events. It must be 
mentioned that these stages are not 
necessarily sequential but usually represent 
concurrent events. Likewise, although 
certain cytokines dominate in some stages, 
overlap will always be observed because of 
cytokine pleiotropism. In general, 
inflammation likely depends upon a 
balance of proinflammatory (e.g. IL-1,     
IL-18, TNF-, IL-8 etc.) and antiinflammatory (e.g. IL-18 binding protein, IL-1ra, IL-4,  
IL-10, IL-13 etc.) signals that constantly changes as the response evolves and resolves. 
 
 
Fig. 5. Stages of immune and inflammatory responses. Cytokines can be associated with the stage of 
the response they most influence. Some cytokines can affect all stages, others are more restricted in 
their activity. [1] 
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2.1. Chemokines 
The word chemokine is a shortening of chemoattractant cytokines. This term indicates 
the main function of this family of small, secreted proteins, which is the induction of 
chemotaxis in a variety of leukocytes. To date, at least 40 distinct chemokines have been 
well characterized. In addition to their chemotactic capacity, they have a plethora of further, 
partly overlapping functions and are produced by a big variety of cells. Generally, 
chemokines act on more than one type of leukocyte, and in vitro responses include 
chemotaxis, enzyme release from intracellular stores, oxygen radical formation, shape 
change through cytoskeletal rearrangement, generation of lipid mediators and induction of 
adhesion to endothelium or extracellular matrix proteins. There is now considerable 
evidence to indicate that the coordinate expression of chemokines and adhesion molecules 
is responsible for selective trafficking of leukocyte populations from intra- to extravascular 
compartments. More recently, chemokines and their receptors have been shown to play a 
key role in the regulation of angiogenesis [3] and neuronal cell regulation [4]. 
As leukocyte recruitment appears to be an essential step in the development of 
inflammation, the topic of regulation of chemokine expression is of pivotal importance in 
the attempt to understand regulation, function, and pathophysiology of inflammatory 
processes. [5] 
 
2.1.1. Structure and Function of Chemokines 
Chemokines are 6 to 14 kDa proteins with 20 to 70 percent homology in amino acid 
sequences. They have been subdivided into families on the basis of the relative position of 
their cysteine residues. There are at least four families of chemokines, but only two have 
been extensively characterized. The - and -chemokines which are encoded on 
chromosomes 4 and 17, respectively, appear to be the largest families. In the -chemo-
kines, one amino acid separates the first two cysteine residues (cysteine  any amino acid 
(X)  cysteine, or CXC), whereas in the -chemokines, the first two cysteine residues are 
adjacent to each other (cysteine  cysteine, or CC).  
The  -chemokines can be further subdivided into those that contain the sequence 
glutamic acid – leucine – arginine near the N-terminal, preceding the CXC sequence, and 
those that do not. The -chemokines containing this sequence are chemotacic for 
neutrophils, whereas those not containing it act on lymphocytes.  
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The  -chemokines, in general, do not act on neutrophils, but attract monocytes, 
eosinophils, basophils, and lymphocytes with variable selectivity. As with the CXC family, 
the N-terminal amino acids preceding the CC residues are critical components of the 
biologic activity and leukocyte selectivity of these chemokines. 
Several chemokines, e.g. IL-8, undergo N-terminal proteolytic processing after 
secretion, which alters their activity. This may reflect a general mechanism that allows local 
factors to regulate and amplify chemokine function.
 
2.1.2. Chemokine Receptors  
Chemokines induce cell migration and activation by binding to specific G-protein 
coupled cell surface receptors, so-called sevenspanners, on target cells. Chemokine 
receptors are expressed on different types of leukocytes. On some cells they are 
constitutively expressed, while they are inducible on others: CCR1 and 2 are always found 
on monocytes but only after stimulation by IL-2 on lymphocytes. Some constitutive 
chemokine receptors can be downregulated. 
Another interesting finding was that some chemokine receptors are expressed on T cells 
depending on their state of differentiation, e.g., CXCR3 being present on T helper cells in 
the cell-mediated Th1-type immune responses, while an allergic Th2 type reaction would 
favour CCR3. In this way, transient upregulation of chemokine receptors on leukocytes 
allows for specific amplification of either a Th1- or Th2-type response. 
Some chemokine receptors are also expressed on nonhematopoietic cells, including 
neurons, astrocytes, epithelial cells, and endothelial cells. This suggests, in concordance 
with the findings mentioned at the beginning of this section, that the chemokine system has 
other roles in addition to leukocyte chemotaxis. 
Chemokine receptors, like other members of the family of G protein coupled receptors, 
are functionally linked to phospholipases through Gi or Gq proteins. Many chemokine-
induced signaling events are inhibited by Bordetella pertussis toxin, suggesting that 
chemokine receptors are linked to G proteins of the Gi or Go class. Receptor activation 
leads to a number of cellular activation cascades, involving the second messengers IP3, 
Ca
2+, and diacylglycerol which targets protein kinase C. Similar to other ligands of Gi 
receptors, chemokines inhibit adenylyl cyclase and thus decrease cAMP levels. 
Interestingly, also Rho protein mediated processes (e.g. pseudopod formation) are induced, 
which take part in cell motility regulation. [6] Thus, chemokine receptors activate multiple   
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intracellular signaling pathways that regulate the intracellular machinery necessary to 
propel the cell in the required direction. 
The production of proteins with cytokine-antagonizing functions is an important 
regulatory principle in cytokine biology. Examples are IL-1 receptor antagonist and IL-18 
binding protein, which oppose IL-1 and IL-18 functions, respectively. Furthermore, the 
Duffy antigen receptor for chemokines (DARC), found on erythrocytes and endothelial 
cells, as well as soluble IL-1 receptors both function as sinks for their respective ligands. 
E.g., both CC and CXC type chemokines bind to the DARC, but do not induce calcium 
flux. Thus chemokines are cleared from the circulation, and local concentration gradients 
can be more easily upheld where needed.  
 
 
 
 
2.2. Details about chemokines and cytokines relevant to my investigations 
2.2.1. Interleukin 8 
In 1988, IL-8 was the first cytokine to be identified as an inducer of leukocyte migration. 
It is thus still considered a prototype of the chemokine family and many of the properties 
originally ascribed to IL-8 are still generally valid for the 50 or so human chemokines that 
have been described so far. IL-8 is produced and secreted by a wide variety of cells 
including M, neutrophils, T-cells, mesangial cells, endothelial cells, fibroblasts, 
keratinocytes, hepatocytes, and chondrocytes. The encoding gene is located on 
chromosome 4 and some of the details of the intricate regulation of IL-8 expression have 
been elucidated. E.g., the 5´-promoter region of the human IL-8 gene is known to contain 
potential binding sites for a number of regulatory factors, including NF-B and AP-1. On 
the transcriptional and translational level, members of the MAP-kinase stress pathway, 
particularly p38 MAP kinase, play a role in activation of IL-8 expression.  
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Fig. 6. Left: Human IL-8. Top right: A three dimensional minimized mean structure of the 
polypeptide backbone of human recombinant IL-8. Bottom right: Schematic representation of the 
seven transmembrane spanning IL-8 receptor which is G-protein coupled and belongs to the 
rhodopsin superfamily. [2] 
 
The 8 kDa, 72 residue-protein IL-8 is a member of the -subgroup of the chemokines 
( section 2.1.1.) and thus predominantly acts on neutrophils. It regulates their migration 
to inflammatory sites by enhancing their attachment to activated endothelial cells. 
Neutrophils encounter IL-8 bound to endothelial cells during selectin-mediated rolling. 
Since activated endothelial cells (and other immune cells) at inflammatory sites secrete   
IL-8, a chemokine concentration gradient forms along the vessel wall, with the highest IL-8 
concentrations at the site of tissue damage. As neutrophils sample this gradient, they 
become activated and upregulate membrane expression of -2-integrins. These adhesion 
molecules are rapidly integrated into the cell membrane and are then able to interact with 
their counterparts on the endothelial cells, ICAM-1 (intercellular adhesion molecule 1). It is  
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interesting to note that the surface expression of ICAM-1 on endothelial cells is greatly 
enhanced by IL-1, TNF-, and IFN-. 
In response to the localized, combinatorial effects of chemokines and other 
inflammatory mediators the gathering neutrophils rapidly undergo shape change, form 
pseudopods, and migrate across the microvessel wall to enter the infected or damaged 
tissue. 
In addition to inducing chemotaxis and complementing processes, IL-8 has a plethora of 
further functions, and the list might become even longer as research continues. Refer to 
table 3 for a summary.  
 
Table 3. Functions of IL-8 
Cell Target  Effects 
Neutrophils  Chemotaxis; shape change; apoptosis ; respiratory burst ; 
degranulation  ; lysosomal enzyme release ; cytosolic free Ca
2+  ; 
adherence to endothelial cell monolayers, fibrinogen, and subendothelial 
matrix proteins ; binding of complement factor C3b and LPS ; 
complement receptor type 1 ; surface expression of -2-integrins ; 
phosphorylation of a 48 kDa cytosolic protein ; activation of 5-
lipoxygenase and release of 5-HETE 
T-cells   Chemotaxis 
Basophils  Chemotaxis; histamine release  or ; leukotriene release  
Endothelial cells  Proliferation ; angiogenesis  
Keratinocytes Proliferation   
Melanoma cells  Adhesiveness  
 
 
 
2.2.2. Macrophage Inflammatory Protein 1 
I chose MIP-1 as a representative of the family of CC- or -chemokines ( section 
2.1.1.). As such it is encoded on chromosome 17. Like IL-8, MIP-1 is an 8 kDa protein. 
One of the stimuli for secretion of MIP-1 is LPS. 
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While the mode of action of MIP-1 
is similar to IL-8 ( section 2.2.1.), the 
cellular targets are not neutrophils, but 
preferably M as well as T- and B-
lymphocytes. Additional functions are 
listed in table 4.            Fig. 7. [2]   
 
Table 4. Functions of MIP-1 
Cell Target  Effects 
M  Chemotaxis; respiratory burst ; degranulation ; lysosomal enzyme 
release ; prostaglandin-independent endogenous pyrogen ; myelopoeitic 
enhancing activity 
CD8
+ T-cells  Chemotaxis; adherence to activated endothelial cells  
B-cells   Chemotaxis 
Stem cells  Growth inhibition 
Basophils  Histamine release  
     ---  Binding of heparin 
 
2.2.3. Interleukin 1 
Interleukins are a variety of polypeptide mediators that modulate leukocyte activity. The 
term interleukin was intended to bring a standard usage to a confusion of nomenclature that 
was based upon biologic activities. 
Before the baptism to its current 
name, IL-1 had various names, 
which reflects its highly 
pleiotropic characteristics. The 
molecule exists in two structurally 
related isoforms, IL-1 and IL-1, 
which bind to the same receptor 
and exert similar functions. The 
17.5 kD proteins are a product of a variety of cells, including M, PML, lymphocytes, glial 
cells, endothelial and other cells. Microbial products (LPS, viruses) and other cytokines can  
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induce IL-1 synthesis. Its known in vitro proinflammatory biologic activities include 
stimulation of T-lymphocyte proliferation, chemokine synthesis, NO synthesis, 
prostaglandin synthesis, and expression of endothelial adhesion molecules. In vivo, IL-1 
appears to contribute to neutrophilic leukocytosis, fever, and acute phase protein 
production. IL-1 also induces glucocorticoid release, which potentially provides an 
immunoregulatory feedback circuit. M also produce IL-1 receptor antagonist, a natural 
inhibitor which tempers the biologic effects of IL-1. 
 
2.2.4. Tumor Necrosis Factor           Fig. 9. Human TNF-[2] 
TNF- was first discovered in 
the plasma of animals challenged 
with bacterial endotoxin and was 
found to cause necrosis in tumor 
cells in vivo and in vitro. TNF- is 
a 17 kDa protein that usually exists 
as a trimer and is produced 
primarily by activated M. Like 
IL-1 it is a highly pleiotropic 
cytokine and most of its functions 
overlap with those of IL-1. 
Parenteral administration of TNF 
causes fever, leukopenia, and 
hypotension. Animal studies 
indicate that, together with IL-1, 
TNF may be a critical mediator of 
septic shock and the cachexia of 
chronic disease. TNF has many 
inflammation-related actions, 
including the induction of multiple 
cytokines, adhesion molecule 
expression, bone and cartilage 
resorption, fibroblast proliferation, 
collagen synthesis, angiogenesis, and acute phase protein synthesis.  
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2.2.5. Interleukin 10 
IL-10 is among the most important anti-inflammatory cytokines found within the human 
immune response. The 35 to 40 kDa protein is primarily synthesized by CD4
+ Th2 cells, 
M, and B cells and circulates as a homodimer consisting of two tightly packed 160-amino 
acid molecules. IL-10 utilizes a cytokine receptor type II which activates the intracellular 
Jak (Janus tyrosine kinase) – Stat (signal transducer and activator of transcription) pathway 
[7]. In Th1 cells, Stat3 DNA-binding results in suppression of cytokine production, 
including both IL-2 and IFN-. After engaging its 110 kDa receptor on monocytes, IL-10 
suppresses their production of IL-1, TNF, IL-6, IL-12, and granulocyte colony-stimulating 
factor, as well as chemokine synthesis. Furthermore, it inhibits cell surface expression of 
major histocompatibility complex class II molecules on these cells and thereby impairs 
their capacity to present antigen to Th1 cells. IL-10 also inhibits translocation of NF-B 
after LPS stimulation and promotes degradation of mRNA for the pro-inflammatory 
cytokines. Moreover, IL-10 is a B cell stimulant, promoting proliferation, differentiation, 
and antibody production. It also synergizes with IL-3 and IL-4 to stimulate mast cell 
growth. The above characteristics underline the important antiinflammatory properties of 
IL-10 which are enhanced when it acts in concert with IL-4 and IL-13. 
 
2.2.6. Transforming Growth Factor   Fig. 10. Human TGF-1 [2] 
TGF- is the name of a family of 
cytokines which distinguishes itself 
from other ones by the ability of its 
members to influence almost every 
facet of the immune response, inclu-
ding the growth and differentation of 
precursors for multiple haematopoetic 
lineages, the proliferation and migra-
tion of mature immune cells (e.g. M) 
and fibroblasts into sites of injury or 
response, and the suppression of such 
responses once they have been estab-
lished. Furthermore, TGF- plays a 
role in angiogenesis as well as cytokine regulation; in this regard especially its anti- 
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inflammatory actions (downregulation of IL-1 and TNF- production in M) play a role in 
the context of my experiments. The complimentary autocrine, paracrine, and even 
endocrine modes of TGF- activity have been delineated through extensive in vitro and in 
vivo analyses of function [e.g. 8]. 
Today, three isoforms of TGF- called TGF-1,2, and 3, are known. They all bind to the 
same receptor. TGF-, which is considered the prototype of the group, is the molecule I 
used as a modulating agent in my experiments. It is expressed by all immune cells and is 
the isoform most often acutely regulated in response to a variety of stress and disease 
signals.  
The signals from TGF- ligands are mediated by a receptor complex which is 
noteworthy for inducing an intrinsic serine-threonine kinase activity as opposed to receptors 
for other immunoregulatory cytokines that often signal through tyrosine kinase-mediated 
pathways. The downstream signalling cascade involves the SMAD proteins which carry the 
signals from the cell surface directly to the nucleus. [9] 
 
 
 
3. Stress 
Cells are complex units, the survival and function of which depends on the delicate 
balance between intra- and extracellular events. Understanding the causes and mechanisms 
of reversible and irreversible injury inflicted on cells, as well as their reaction to the 
respective form of stress or injury is a prerequisite for an appreciation of the biologic basis 
of disease processes. It is valuable for determining the therapeutic regimen, in anticipating 
the short- and long-term sequelae of a given pathologic process, and in implementing 
effective preventive measures. This section not only introduces some of the etiologic agents 
that can cause cellular stress, but also the mitogen-activated protein kinase (MAPK) family, 
an important signaling pathway in cellular responses to stress. 
 
 
3.1. p38 Mitogen-Activated Protein Kinases and SB203580 
Since the discovery of p38 MAPK in 1994, interest in the family of the MAPK has 
steadily been growing. In addition to their initial implication with inflammatory processes, 
a variety of functions has been reported, including mediation of signals triggered by  
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cytokines, growth factors, and environmental stress. More recently, MAPK have been 
associated with cellular development and differentiation, e.g. of cells of the immune 
system. This diversity not only underscores the central position of the MAPK in signal 
transduction, but also shows why clinical applications based on modulation of MAPK 
activity met with unexpected difficulties.  
It is now known that there are four members of the MAP kinase family: the extracellular 
signal regulated kinases (ERK), p38, and c-Jun N-terminal kinases (JNK). They differ in 
their tissue distribution, regulation of kinase activation and subsequent phosphorylation of 
downstream substrates. The following section focuses on the p38 subgroup. 
The MAPK families all consist of several members and in the case of p38 these are 
called p38,  ,  , and 	. This is noteworthy, because despite amino acid sequence 
homologies of approximately 90 %, 63 %, and 61 % to p38, respectively, only p38 and 
 are affected by the MAPK inhibitor SB203580.  
This compound, which I used in my experiments, belongs to the pyridinylimidazoles. 
These substances were originally described as inflammatory cytokine synthesis inhibitors 
that subsequently were found to be selective inhibitors of p38 MAP kinases. SB203580 
inhibits the catalytic activity of p38 and  MAP kinase by competitive binding to the  
ATP pocket. 
While the  and the  isoforms are ubiquitously expressed, the expression of p38 and 	 
is more restricted to skeletal muscle and glandular organs, respectively. All members of the 
p38 family possess a 12 amino acid activation loop containing a Thr-Gly-Tyr motif which 
is phosphorylated by upstream MAP kinase kinases (MKK). 
As mentioned above, p38 MAPK are involved in a wide variety of signaling pathways. 
E.g., in cells exposed to pro-inflammatory cytokines or environmental stresses, p38 MAPK 
is activated which leads to phosphorylation of heat shock proteins (HSP) as well as 
strathmin which are involved in cytoskeletal reorganisation. HSP also have protective 
functions against oxdative stress. p38 MAPK also are involved in the regulation of 
phospholipase A2, a key enzyme in the transduction of signals associated with inflammation 
and pain. In monocytes, p38 MAPK can upregulate c-Jun transcription and thereby 
influence host defense and inflammation. Moreover, through phosphorylation of p47, p38 
kinases take part in enhancing the respiratory burst in activated neutrophils. 
A view upstream in the signaling cascade reveals equally interesting details. For 
example, an isoenzyme of the above mentioned MKK, MKK6, appears to play a role in  
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cooperation with caspase 1 in signal transduction of apoptosis in T-cells. G-protein coupled 
receptors have also been found to be able to activate MAPK.  
The greatest relevance of the MAPK to our studies, however, lies in their capacity to 
regulate cytokine biosynthesis in many different cell types. Transcript stability of IL-6 and 
IL-8 in monocytes is increased with enhanced activation of p38. Likewise, p38 MAPK-
function is essential for TNF biosynthesis on a post-translational level in these cells and for 
IL-12 and IFN- expression in T cells. In B lymphocytes, p38 activates NF-kB and induces 
cell proliferation and expression of adhesion molecules. Nevertheless, p38 MAPKs also 
play their part in anti-inflammatory signaling: in dendritic cells they mediate IL-10-induced 
effects, such as downregulation of TNF- production, suppression of endocytosis, and 
chemotactic migration. [10, 11] 
With research showing ever new facets and details of MAPK-function, the enzymes and 
their specific inhibitors naturally evoke interest in possible clinical applications. Animal 
models have shown that SB203580 is capable to attenuate arthritis, decrease lethality of 
septic shock, reduce inflammatory activity in chronic obstructive lung disease (COPD) and  
 
 
                 Fig. 11. [10] 
 
asthma, and act as a protector of neurons as well as myocytes after ischaemic insults. In all 
cases, p38 activation in key cell types correlated with disease initiation and progression. 
Treatment with p38 MAP kinase inhibitors attenuated both p38 activation and disease 
severity. Structurally diverse substances have been tested extensively in preclinical studies; 
some newer generation compounds with fewer undesirable effects have even entered the 
clinical phases. [10] 
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3.2. Reactive Oxygen Species 
Although oxygen is essential for the survival of cells it carries a definite risk of injury 
which occurs when cells are exposed to excess oxygen radicals. This occurs, among others, 
during immune responses or hyperoxic conditions as seen in treatments with high partial 
pressures of oxygen. The impact of these effects is particularly pronounced when the 
natural protectants of cells against the deleterious effects of activated oxygen species (i.e. 
antioxidants) are deficient in quantity.  
PML and M as well as certain local resident cells generate reactive oxygen species 
(O2
-, H2O2, OH
) as their means of killing exogenous biologic materials or abnormal cells. 
For example, in bacterial sepsis (endotoxic shock) severe intravascular stasis of PML can 
occur within the lung. These neutrophils liberate oxygen radicals and damage capillary 
endothelium, causing diffuse alveolar damage, which progresses even further as storage 
pools of cellular antioxidants become depleted. 
The potency and biologic toxicity of different reactive oxygen species varies 
considarably. O2
- is relatively weak and diffuses poorly across cell membranes. H2O2 is also 
a weak oxidant, but it can readily diffuse into the cytoplasm from organelles where it is 
produced. It also diffuses across plasma membranes. On the other hand, OH
 is an 
extremely reactive chemical that phagocytes use to attack microbes or necrotic cell debris, 
but it can also attack vital endogenous molecules within living cells and lead to cell injury 
or death. It is worthy of note that ionizing radiation produces OH
 along with a variety of 
other free radical species in a dose dependent manner. [12] 
Reactive oxygen species cause cell injury by oxidation of critical cellular 
macromolecules such as proteins, DNA, and lipids. They can also oxidize thiols, leading to 
the formation of protein disulfides and protein mixed disulfides. They are also known to 
interact with cytoskeletal elements and interfere with mitochondrial oxidative 
phosphorylation and cause ATP depletion. Of considerable interest, however, is that OH
 
and other reactive oxygen species interact with polyunsaturated fatty acids (PUFA) in a 
rapid-fire fashion to yield highly destructive PUFA radicals, lipid hydroperoxy radicals, and 
lipid hydroperoxides. This process is known as lipid peroxidation. The lipid peroxides are 
decomposed by transition metals, such as iron, to yield conjugated dienes, pentane, and 
ethane, which can be measured and serve as indicators of lipid peroxidation. Furthermore, 
toxic reactants are generated during lipid peroxidation. Lipid peroxidation propagates to 
cellular sites distant from the original injury, resulting in widespread membrane damage.   
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Finally these processes change the integrity of the membranes and result in influx of 
water and Na
+ and Ca
2+ ions. The cells can then be recognized by their enlarged size and 
their pale, cloudy, and granular cytoplasm. If the damage cannot be rapaired, death soon 
ensues. 
 
 
3.3. Nitric Oxide 
Nitric oxide (NO) was recognized in the 1980s as a free radical with important 
physiologic functions. First, it was identified as the endothelium-derived relaxing factor 
(EDRF) which plays a major role in the regulation of the vascular tone. Soon after, other 
functions were discovered: NO also is an effector molecule responsible for the cytostatic 
effect of activated M on tumor cells and pathogens such as certain bacteria and viruses. 
The involvement of NO in the induction of apoptosis shall be discussed later in this section. 
NO can react with the superoxide radical (O2
-) to form peroxynitrite (ONOO
-) or can 
induce or promote the formation of other reactive oxygen species. Radicals formed from 
NO are known to inhibit mitochondrial respiration. In addition, NO was found to act as a 
neuromediator implicated in long-term potentiation and it displays retrograde messenger 
activity. 
NO is formed by the conversion of L-arginine to L-citrulline by a family of enzymes, the 
NO synthases (NOS), three of which have been identified to date. They are encoded by 
genes located on different chromosomes and differ in their properties. Type 1 or neuronal 
NOS (nNOS) and type 3 or endothelial NOS (eNOS) are expressed constitutively by 
various cell types, e.g. neuronal cells, vascular endothelium, skeletal myocytes, and others. 
In response to specific activators of these cells (e.g. neuromediators, bradykinin, etc.), the 
enzymes become activated by transient increases of the intracellular concentration of free 
Ca
2+. They then release brief `puffs´ of NO, creating small concentration gradients which 
are utilized in cellular signaling, e.g. via activation of soluble guanylate cyclase in 
neurotransmission or in relaxation of smooth muscle fibers of arterioles. 
A third enzyme, the Ca
2+-independent type 2 or inducible NOS (iNOS) is 
transcriptionally regulated. iNOS is not expressed in resting cells in physiological 
situations, but can be induced following activation, mainly by cytokines, but also by other 
stimuli, such as hypoxia. Both cytokine release and hypoxia occur during the course of an 
inflammatory response and may act in synergy for the induction of iNOS. This implicates   
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that one major role of iNOS is to participate in the nonspecific defense of the host against 
invading pathogens and thus to contribute to innate immunity. 
NO is often described as a double edged sword as it exerts opposite effects depending on 
its concentration and the target cell type. Although this is particularly true for its role in 
apoptosis, the focus of discussion in this dissertation shall be on the pro-apoptotic aspects 
since induction of apoptosis, through NO or other mediators, is an important means of the 
immune system in dealing with dysplastic or virus-infected cells. 
NO interferes with enzymatic components of the mitochondria causing reversible 
inhibition of the respiration, but also irreversible inactivation of some mitochondrial 
enzymes containing Fe-S or heme moieties, to which it displays a high affinity. For a 
variety of proteins the binding of NO to heme leads to reversible inhibition of the functions 
of these proteins. One example is cytochrome oxidase: by competing with oxygen for this 
enzyme, low concentrations of NO inhibit electron transport. This in turn leads to 
impairment of respiration and ATP synthesis and finally to a release of mitochondrial Ca
2+ 
into the cytoplasm. 
Other proteins are irreversibly inactivated by NO, such as enzymes of the respiratory 
chain (complexes I, II, and III) and of the citric acid cycle (aconitase) which contain Fe-S 
clusters, as well as GAPDH via S-nitrosylation. This results in iron release with consecutive 
formation of OH
, as well as an inhibition of glycolysis and further reduction of ATP 
production. These alterations of the energy metabolism of the cell will in turn affect Ca
2+ 
levels, this time by preventing an efficient activity of the Ca
2+-ATPases of the plasma 
membrane and the endoplasmatic reticulum, leading to dramatic increases of cytoplasmatic 
Ca
2+. 
The above processes cause the inner mitochondrial membranes to swell, eliciting 
increased permeability for components of the mitochondrial matrix which are released into 
the cytoplasm. These include molecules involved in the control of apoptosis, such as 
apoptosis protease activating factor 1 (APAF-1) and cytochrome c. The latter, in 
conjunction with dATP, activates caspase 9 which stimulates the downstream caspase 3, 
leading to the proteolysis of inhibitor of caspase activated DNase (ICAD). The degradation 
of ICAD allows the CAD endonuclease to migrate to the nucleus and to exert its enzymatic 
activity, ultimately resulting in the internucleosomal cleavage of DNA. 
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In addition, NO is known to stimulate the process of pro-caspase activation in various 
cells as well as to inhibit ribonucleotide reductase, an enzyme involved in the production of 
deoxyribonucleotides, which leads to impairment of DNA synthesis and cell proliferation. 
Finally, in some cells NO causes mutations and DNA strand breaks which leads to 
activation of the tumor suppressor protein p53. This in turn either induces a stable growth 
arrest or apoptosis. [13, 14] 
 
 
3.4. Hyperosmolarity 
Hyperosmolarity has recently gained clinical significance as research suggests an 
important role in the pathogenesis of cystic fibrosis as well as exercise-induced asthma. 
Recent investigations have shown that hyperosmotic stress induces the production and 
release of proinflammatory cytokines, such as IL-1 and IL-8, mediated by free oxygen 
radicals which activate p38 MAPK pathways. [15, 16] 
 
 
3.5. Heat shock 
Virtually all organisms respond to up-shifts in temperature (heat shock) by synthesizing 
a set of so-called heat shock proteins (HSP). The HSP are induced not only by heat shock 
but also by various other environmental stresses. Induction of HSP is regulated by the trans-
acting heat shock factors (HSF) and the cis-acting heat shock element (HSE) present at the 
promoter region of each heat shock-sensitive gene. Usually, HSP are also expressed 
constitutively at normal growth temperatures and have basic and indispensable functions in 
the life cycle of proteins as molecular chaperones, as well as playing a role in protecting 
cells from the deleterious stresses. Molecular chaperones are able to inhibit the aggregation 
of partially denatured proteins and refold them using the energy of ATP. There are 
expectations for the use of molecular chaperones for the protection against and therapeutic 
treatment of inherited diseases caused by protein misfolding. 
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3.6. Cytotoxic Substances 
Antineoplastic drugs have effected cures in some forms of cancer, and can produce 
remissions and alleviation of symptoms in other forms. However, these agents are cytotoxic 
also to normal cells and can provoke severe adverse reactions, particularly in cells that are 
rapidly replicating, such as cells of the gastrointestinal mucosa, the germinal epithelium, 
and the hair folliculi, as well as stem cells in the bone marrow. A variety of 
chemotherapeutic agents is used in clinical practice. Among others, these include alkylating 
agents (e.g. cyclophosphamide, busulfane, etc.) and antibiotics (e.g. bleomycin, mitomycin, 
etc.) which suppress cell growth by interacting with DNA replication, antimetabolites (e.g. 
methotrexate, 5-fluorouracil, azathioprin, etc.) which enter into and disrupt cellular 
metabolic functions, and alkaloids (e.g. vincristin, paclitaxel, etc.) that interfere with 
mitotic spindle integrity. However, the ultimate outcome commonly produced by many of 
the cytotoxic substances is the induction of apoptosis in target cells. 
 
 
3.6.1. VP-16 
VP-16 or etoposide is a naturally occurring substance derived from the mayapple plant 
and, together with teniposide, belongs to the family of the epipodophyllotoxins. It is an 
inhibitor of topoisomerase II, an essential enzyme that plays a role in virtually every 
cellular DNA process. This enzyme interconverts different tertiary 
and quaternary structures of DNA by passing one nucleic acid 
segment through a transient double-stranded break which has been 
generated in a second segment. By virtue of its capability to 
rearrange double-stranded DNA, topoisomerase II is able to 
regulate DNA over- and underwinding, and can resolve knots and 
tangles in the genetic material. Beyond these important 
physiological functions, topoisomerase II is the target for 
successful anticancer drugs, such as VP-16 and teniposide, used to 
treat human malignancies which include various neoplasms of the lung,         Fig. 12 [17]    
Hodgkin´s disease, non-Hodgkin´s lymphomas, and acute myeloid leukaemia (AML), as 
well as refractory testicular cancer. These agents are referred to as topoisomerase II 
poisons, because they transform the enzyme into a potent cellular toxin. Topoisomerase II 
poisons act by increasing the concentration of enzyme-cleaved DNA complexes that  
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normally are fleeting intermediates in the catalytic cycle of topoisomerase II. This results in 
an accumulation of enzyme-mediated breaks in the genetic material of treated cells and 
ultimately triggers apoptotic cell death.  
 
Fig 13. A model for DNA topoisomerase II action. The enzyme is composed of discrete structural 
domains bordered by protease sensitive sites (A, B, and C). The free topoisomerase II dimer 
depicted in 1  is shown bound to the gated DNA helix (orange) in stage 2. Stage 3 shows the 
prestrand passage cleavable complex in which the gated helix is in equilibrium between cleavage 
and religation. The transported DNA helix (blue) is entering the complex between the ATPase 
domains. ATP then binds to the complex and induces a conformational change, whereby the 
transported helix is passed through the break in the gated helix. Stage 4 represents the circular 
clamp intermediate, which is trapped by the nonhydrolysable ATP analog AMPPNP. In the 
presence of ATP, this intermediate is transient and is likely to rapidly proceed to stage 5, where the 
transported helix is released through the C-terminal gate. ATP is then hydrolysed to allow the 
enzyme dimer to return to its original conformation.  [17]  
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3.6.2. 2-Chlorodeoxyadenosine 
2-CdA belongs to the family of the antimetabolites and to the subgroup of the purine 
analogs. The action of these drugs evolves from their ability to disrupt the synthesis of 
nucleic acid. However, 2-CdA is unique compared with traditional antimetabolite drugs in 
that it is equally active against dividing and resting lymphocytes because of its interactions 
with adenosine deaminase. By that means 2-CdA decreases not only DNA synthesis, but 
also purine metabolism. Hence, in clinical practice, 2-CdA is of special importance in 
diseases in which most cells are in the resting phase, such as chronic lymphocytic leukemia 
(CLL). Especially in the rare hairy-cell form of CLL extraordinary therapeutic successes 
have been achieved. Furthermore, 2-CdA is effective against several forms of non-
Hodgkin´s lymphoma. As for VP-16 and U-937 cells, it has been demonstrated that 2-CdA 
is a potent inducer of apoptosis in PBMC. [18] 
 
Sections 3.2. to 3.5. have presented some examples for forms of cellular stress. One 
aspect common to all these stressors is the induction of a set of proteins with different 
functions, some of which are protective such as HSPs and hemeoxygenase 1 (HO-1), others 
of which have signaling properties like IL-8. One of the new hypotheses of this work is that 
stress inflicted on cells by cytotoxic substances is dealt with in a way similar to the 
previously observed reactions after exposure to oxygen radicals, NO, etc, namely, among 
others, by the induction of chemokine synthesis and secretion. 
 
 
 
4. Apoptosis and Necrosis 
4.1. Necrosis 
When early pathologists started looking at the first slides with stained tissues over 100 
years ago they looked mostly at sections of organs in which injury was extreme and sudden: 
ischemia after occlusion of a major artery, physical or chemical trauma, or overwhelming 
infection. Necrosis was the term they applied to what they saw.  
In necrosis the critical organelle is the mitochondrion, which begins to swell early on. 
High-amplitude swelling crystals, probably of calcium phosphate, begin to precipitate in the 
mitochondrial lumen. If the process is not reversed, the mitochondrion is no longer able to 
maintain its ionic gradients or oxidative phosphorylation, and the cell runs out of energy.  
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Starving for ATP, the plasma membrane’s ion pumps fail, water floods in, and the cell 
swells and bursts. Lysis releases the cell’s intracellular contents into the extracellular 
milieu, where they have no business being; these internal lipids, proteases and small 
molecules are intensly proinflammatory. They attract white cells, primarily macrophages, 
from around the body. Given the extent of damage, this is usually desirable because the 
local facilities for dealing with damage can be overwhelmed. The net effect of the 
inflammatory process is the removal of debris, resolution of injury, and, if the stroma has 
been damaged, scar formation. 
 
 
4.2. Apoptosis 
A different morphology of cell death was described in 1972 by Kerr, Wyllie, and Currie 
[19]. It was seen in cells for which death was normal and predictable, i.e., cells scheduled to 
live a shorter time than the body as a whole. It was also seen in cells dying of relatively 
minor injury compared to that which leads to necrosis, e.g., around the periphery of 
ischemic lesions. Because this death seemed to be more physiologic than necrosis, it was 
named apoptosis, from a word in the Hippocratic corpus (apo- away; ptosis falling), 
meaning the loss of leaves from trees or petals from flowers. 
The defining morphologic feature of apoptosis is a collapse of the nucleus. Chromatin, 
which is normally composed of mixed open and condensed regions, heterochromatin and 
euchromatin, becomes supercondensed, appearing as crescents around the nuclear envelope   
Fig. 14 [1] A , B                   
and eventually as spherical featureless beads. 
The structural correlate of this morphologic 
change is the fragmentation of DNA, initially into quite large pieces of about 50 to 70 kbp 
and then, in some but not all cells, into units of one or several nucleosomes in length. (A 
nucleosome consists of a core of histone proteins wrapped by about 180 bp of DNA and is 
the first stage of compaction of DNA.) This degradation reflects the action of an 
endonuclease on the DNA in the linkers between nucleosomes, where the strand is  
30  
accessible to the enzyme because it is not protected by histones. The identity of the 
endonuclease is still unresolved, although caspase-activated DNAse, a new candidate, has 
attracted considerable attention. Because cells can only repair a few simultaneous double 
stranded brakes in their DNA, the extensive DNA damage in apoptosis, up to 300.000 
breaks per chromosome, means that even if there were no other changes, the cell would 
certainly never successfully divide again. 
However, other changes do 
take place. Early in apoptosis, 
cells shrink remarkably, losing 
about a third of their volume in a 
few minutes. The mechanism for 
this process is not yet understood, 
but it must involve shifts in ions, 
as well as water, perhaps through 
the unusual activation of plasma 
   Fig 15 [1]                  membrane  associated  ion 
channels or pumps. This shrinkage is quite apparent in cell culture and also in vivo, where 
apoptotic cells in tissue sections often pull away from their neighbours. As might be 
expected, there are also cytoskeletal changes that accompany shrinkage, and the result is a 
peculiar, vigorous “boiling” action of the 
plasma membrane, which has been called 
zeiosis or blebbing. By this action, the 
apoptotic cell usually tears itself apart into 
apoptotic bodies, some of which contain 
chromatin. It is not known how, or even if, 
these changes lead to cell death. This is 
because early in apoptosis, while the cell is 
still fully viable (i.e., able to exclude vital dyes               Fig. 16 [1]                        
like trypan blue), it is recognized by another cell and phagocytosed; it dies within the 
phagocyte. Therefore the real goal of all the morphologic changes may be to ensure that the 
cell gets taken up by another before it has had a chance to spill its dangerous contents. For 
further details, see [20] 
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4.3. Induction of Apoptosis, Fas and Fas-Ligand 
Thymocytes die when exposed in culture to a concentration of glucocorticoid equal to 
that physiologically achieved each day at the peak of the circadian cycle. Wyllie [21] 
showed in 1980 that this death process met the criteria of apoptosis. Steroids work almost 
exclusively by inducing changes in gene expression, usually by transcriptional activation. 
But could transcriptional activation lead to death? It seemed impossible, but when 
thymocytes were treated with a lethal concentration of dexamethasone, in the presence of 
blockers of transcription, the cells did not die. The steroid did not kill the cells; rather, it 
induced them to kill themselves. That is, when they were prevented from expressing what 
came to be called death genes at either the transcriptional (mRNA) or translational (protein) 
levels, they could not die. The important point that these experiments made was this: If one 
cell type has death genes, then all cells in the body do because they share the same genome. 
Therefore any cell in the body could be made to undergo apoptosis if we could understand 
how to get it to turn on these genes, and any cell that intended to die might be prevented 
from doing so by a reverse strategy. The results also suggested that in addition to 
programmed cell death there was a cell death program.  
Recent investigations have provided a more detailed insight into the induction of 
apoptosis via this death program. Besides NO or TNF-, Fas and Fas-Ligand have been 
identified as important mediators of that process. Fas is a transmembrane receptor protein, 
also known as CD95 and APO-1, capable of inducing DNA-damage and consequent 
apoptosis in cells on the surface of which it is expressed. Its cytoplasmic domain is referred 
to as the above mentioned death domain; it is required to transmit the apoptotic signal. The 
intracellular transduction is carried out by the proteolytic caspase cascade, starting with 
caspase 8. It is triggered by the binding of FasL, the ligand of Fas, to its receptor. 
While the receptor Fas is a common protein found in many cell types, FasL is much 
more restricted in its expression. FasL is expressed on cytotoxic T lymphocytes, where it 
contributes to their cytotoxic function and mediates the elimination of peripheral T cells 
following an immune response. Constitutive expression has also been detected in 
immunoprivileged sites such as the eye and testis. [22] The Fas – FasL system as a whole 
has essential roles in immunological self-tolerance and the homeostasis of the lymphocyte 
population. 
Long before the discovery of apoptosis, cytotoxic agents have been used to treat 
malignant diseases on the basis of empirical data – knowledge about their mode of action  
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has caught up with some delay. Today the approach is reversed and new ideas about 
potential therapeutic strategies can be based on sound fundaments layed by research; a good 
example is NO which has been found to induce programmed cell death in various cells, as 
mentioned above. Now the possibility for a reintroduction of a normal apoptotic process in 
leukaemic cells by manipulating their susceptibility to NO or other proapoptotic stimuli can 
be envisaged. 
 
 
 
5. Cells used in our investigations 
5.1. U-937 
U-937 is a monocytoid cell line. It was derived by Sundstrom and Nilsson in 1974 from 
malignant cells obtained from the pleural effusion of a 37 year old caucasian patient with 
diffuse histiocytic lymphoma. Studies since 1979 have shown that U-937 cells can be 
induced to terminal monocytic differentiation by incubation with several substances, 
including IFN- and TNF. They express the Fas antigen and are sensitive to TNF and anti-
Fas antibody-induced apoptotic cells death. They are capable of synthesizing IL-8, 
lysozyme, -2-microglobulin, TNF-, and other important regulators of cell physiology. 
 
 
5.2. Peripheral Blood Mononuclear Cells 
PBMC were obtained from a pool of 12 healthy donors ( Materials and Methods). By 
centrifugation in Ficoll Hypaque solution PBMC were separated from red blood cells, 
platelets, and the polymorphonuclear fraction of white blood cells. This provided us with a 
mixture of approximately 40 – 60 % M and a strongly varying ratio of natural killer (NK) 
cells and T- and B-lymphocytes, depending on the particular donor. A further 24 h 
incubation period on polystyrene plates caused the M to become adhesive. Washing away 
the supernatant thus yielded an approximately 95 % pure culture of M.  
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6. Reagents 
TNF- was kindly provided by Knoll AG (Ludwigshafen). N-tosyl-L-phenylalanine-
chloromethyl ketone (TPCK), SB203580, and VP-16 were from Calbiochem-Novabiochem 
GmbH (Bad Soden, Germany). CdA, Polymyxin B (PmxB), Histopaque-1077, and human 
AB serum were purchased from Sigma (Deisenhofen, Germany). (Z)-1-[2-(2-Aminoethyl)-
N-(2-ammonioethyl)-amino] diazen-1-ium-1,2-diolate (DETA-NO) was from Alexis 
GmbH (Grünberg, Germany). TGF-1 was kindly provided by Dr. N. Cerletti (Novartis, 
Basel). IL-10 was purchased from R&D Systems (Wiesbaden, Germany). All other 
chemicals were either from Merck (Darmstadt, Germany), Sigma, Roth GmbH (Karlsruhe, 
Germany), or from Calbiochem-Novabiochem GmbH. 
 
 
 
7. Cells 
7.1. Cultivation and Treatment of Human Promonocytic U-937 Cells 
The human monocytic cell line U-937 was obtained from the American Type Tissue 
Collection (Rockville, MD). The cells were maintained in RPMI 1640 supplemented with 
25 mM HEPES, 100 U/ml penicillin, 100 g/ml streptomycin and 10% (v/v) heat-
inactivated FCS (GIBCO BRL, Eggenstein, Germany) using 175 cm
2 polystyrene flasks 
(Greiner, Frickenhausen, Germany). For the experiments, 3 ml of cell suspensions were 
seeded into 6-well polystyrene plates (Greiner) at 10
6 cells/ml. Modulators of IL-8 release 
were given 30 min before exposure to VP-16. After the indicated time periods, cells were 
centrifuged and cell-free supernatants were assayed for cytokine concentrations. Cells were 
lysed either for determination of apoptotic DNA fragmentation or for analysis of 
expression of specific mRNA species. VP-16, TPCK, and SB203580 were dissolved in 
DMSO. DMSO concentrations in the cultures were 0.026% (v/v) or below. DMSO did not 
influence release of IL-8 from U-937 cells (711  150 pg/ml versus 714  147 pg/ml for 
control and DMSO (0.026%), respectively; n = 4). In addition, controls were corrected for 
vehicle. All incubations of either U-937 cells or PBMC were performed at 37 
oC and 5% 
CO2 for the indicated time periods. 
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7.2. Isolation and Cultivation of PBMC 
The study protocol and consent documents were approved by the Ethik Kommission of 
the Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main. Healthy 
volunteers abstained from using any drugs during two weeks before the study. Adherent 
PBMC, which constitute a monocyte-enriched fraction, were isolated as follows: Blood 
was drawn in heparinized syringes. PBMC were isolated by centrifugation through Ficoll 
Hypaque (Sigma) at 1000 g for 13 min. PBMC were washed twice in isotonic NaCl 
solution and cultivated in RPMI 1640 supplemented with 25 mM HEPES, 100 U/ml 
penicillin, 100 g/ml streptomycin and 1% (v/v) heat-inactivated human AB serum. For 
evaluation of cytokine expression PBMC were resuspended at 3 x 10
6 cells/ml and were 
seeded in polystyrene 24-well plates or 6-well plates at 1 ml or 2 ml per well, respectively. 
Nonadherent cells were removed by aspiration after a 2.5 h incubation period. CdA was 
dissolved in DMSO (final concentration of DMSO: 0.1% or 0.025%). In all experiments 
performed either with PBMC or with whole blood cultures, polymyxin B (PmxB) was 
added to the different concentrations of CdA (final concentration of PmxB: 1 g/ml) in 
order to ensure that the results were not due to endotoxin contamination either from the 
CdA or from the cell culture medium. Unstimulated controls were incubated with vehicle 
(PmxB and DMSO). 
 
 
7.3. Human Whole Blood Cultures 
 
Whole blood cultures were performed as follows: Vehicle or CdA in the respective 
concentrations were added to culture medium (RPMI 1640 supplemented with 25 mM 
HEPES, 100 U/ml penicillin, 100 g/ml streptomycin). As mentioned earlier, CdA was 
routinely treated with PmxB. Heparinized blood was mixed with an equal volume of 
culture medium and 1 ml aliquots were transferred into round-bottom polypropylene tubes 
(Greiner). The sealed tubes were incubated upright at 37 
oC and 5% CO2 for the indicated 
time periods. Controls were incubated with vehicle only (PmxB and DMSO). Thereafter, 
Triton X-100 was added to a final concentration of 1%. The tubes were mixed until the 
blood became transparent. The lysed blood was stored at -70 
oC until IL-8 concentrations 
were determined by ELISA. 
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8. Methods 
8.1. Enzyme-Linked Immunosorbent Assay 
8.1.1. Principles 
The ELISA is a highly versatile, sensitive, and quantitative technique. The protocol can 
be varied not only to detect specific antibodies or cell surface or soluble antigens, but also 
for epitope mapping and other purposes. In my experiments, I applied the antibody-
sandwich method to quantify IL-8, MIP-1, TNF- (  below), and oligonucleosomes       
( section 8.1.3.). 
In this protocol, a capture 
antibody is absorbed onto a 
microtiter plate. After a blocking 
step in which the non-specific 
binding sites are saturated with 
incubation buffer, which 
contains a certain mix of proteins 
(e.g. 10 % fetal calf serum), the 
test solution containing the 
respective antigen is added. The 
plate is left at room temperature 
for two hours, then the wells are 
thoroughly washed. Another one 
hour period follows, in which the 
immunocomplexes are  incuba-
ted with secondary reactants co-
valently coupled to an enzyme. 
Unbound conjugates are washed 
out and chromogenic substrate is 
added. As the substrate is hydrolyzed        Fig. 1. [22a]               by the 
bound enzyme conjugate, a coloured product is generated. Finally, this product is detected 
with a microtiter plate reader. The amount of product generated is proportional to the 
amount of analysate in the test mixture ( fig. 1). 
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8.1.2. Details 
Cell culture supernatants were analyzed for concentrations of IL-8 and TNF- 
(Pharmingen) by ELISA according to the manufacturer´s instructions. For human MIP-1, 
I used a sandwich ELISA which was established recently [23]. Briefly, a 96-well plate 
(Greiner) was coated overnight with 100 ng/well of anti-human MIP-1 monoclonal 
antibody (Pepro Tech Inc., Frankfurt, Germany) in 100 l/well of coating buffer (0.1 M 
carbonate, pH 9.5). All incubations were carried out at room temperature. After blocking 
with 400 l of 10% (v/v) FCS in phospate-buffered saline (PBS) for 2 h and a single wash 
with 0.05% (v/v) Tween-20 in PBS (washing-buffer), 100 l/well of MIP-1 standards 
(R&D Systems, Wiesbaden-Nordenstadt, Germany) or samples were added in the 
respective dilution made in PBS/10% (v/v) FCS. Plates were incubated for 2 h. After six 
washing steps in washing buffer, 33 ng/well of the polyclonal anti-MIP-1 antibody (Pepro 
Tech Inc., in 100 l/well TBST (Tris-buffered saline, pH 7.5, containing 0.5% (v/v) 
Tween-20)/0.3% (v/v) of FCS) was added and incubated for 1 h. Thereafter, plates were 
washed six times with washing buffer, followed by a 0.5 h incubation with 100 l/well of 
anti-rabbit IgG-horseradish peroxidase conjugate (Biorad, München, Germany) as the 
detecting antibody at a 1:15000 dilution in TBST. After nine washes and addition of 
substrate (Sigma), color development was determined using OD450/595 nm in an ELISA 
reader (BioRad). 
 
8.1.3. Cell Death Detection ELISA and DNA Fragmentation Assay 
8.1.3.1. Principles 
During apoptosis, Ca
2+ and Mg
2+ dependent endogenous DNA endonucleases are 
activated as described in section 4.2. One of these enzymes cleaves double stranded DNA 
at the most accessible internucleosomal linker region, generating mono- and 
oligonucleosomes. In contrast, the DNA of the nucleosomes is tightly complexed with the 
core histones and is therefore protected from cleavage by the endonuclease. The DNA 
fragments yielded are discrete multiples of a 180 bp subunit which can be made visible as a 
“DNA ladder” by agarose gel electrophoresis after extraction and separation of the 
fragmented DNA. This was performed in the experiment described in section 11.1. The 
enrichment of mono- and oligonucleosomes in the cytoplasm of the apoptotic cell is due to 
the fact that DNA degradation occurs several hours before plasma membrane breakdown. 
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8.1.3.2. DNA Fragmentation Assay 
U-937 cells (20 x 10
6 cells/85 mm polystyrene plate) were incubated for 6 h in the 
presence or absence of VP-16 (3.1 g/ml). Thereafter, cells were lysed in lysis-buffer (50 
mM Tris/HCl pH 7.5, 20 mM EDTA, 1% NP-40) and cytosolic DNA fragments 
characteristic of apoptotic cell death were isolated as follows: The lysates were incubated at 
56 
oC in 1% SDS containing 30 l RNase A. After 2 h, proteinase K at a final 
concentration of 1 mg/ml was added and the mix was incubated at 37 
oC over night. The 
lysates were then precipitated over night at -20 
oC by addition of 0.5 volumes NH4 and 2.5 
volumes 100% ice-cold ethanol. The precipitates were washed twice in ice-cold 70% 
ethanol, dried, and resuspended in 40 l DEPC-H2O. This solution was incubated at 37 
oC 
over the weekend. Finally, electrophoresis was performed using a 1.5% agarose gel. DNA 
was stained using ethidium bromide at 0.5 g/ml. 
 
8.1.3.3. Cell Death Detection ELISA 
The cell death detection ELISA by Boehringer Mannheim is based on the quantitative 
sandwich enzyme immunoassay principle using mouse monoclonal antibodies directed 
against DNA and histones. This permits a specific determination of mono- and 
oligonucleosomes in the cytoplasmatic fraction of cell lysates. 
In the first incubation step, anti-histone antibody is fixed absorptively onto the wall of 
the well of the microtiter plate. Subsequently, non-specific binding sites on the wall are 
saturated by treatment with incubation buffer (blocking solution). During the second 
incubation step, the nucleosomes contained in the sample bind via their histone components 
to the immobilized anti-histone antibody. In the third step, anti-DNA-peroxidase (POD) 
reacts with the DNA part of the nucleosome. After removal of unbound POD conjugate by 
a washing step, the amount of POD retained in the immunocomplex is determined 
photometrically with ABTS
 (2,2´-azino-di-[3-ethylbenzthiazoline sulfonate (6)] as 
substrate. For further details see manufacturer´s instructions.  
 
 
8.2. Reverse Transcription Polymerase Chain Reaction 
8.2.1. Principles 
The theoretical basis of the PCR was probably first described in a paper by Kleppe et 
al. in 1971 [24]. However, this technique did not excite general interest until the mid-
1980s, when Kary Mullis and co-workers developed it into a method that could be used to  
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generate large amounts single-copy genes from genomic DNA [25]. In 1988 Saiki et al. 
introduced the thermostable DNA polymerase from Thermophilus aquaticus which not 
only greatly facilitated the process, but also improved the specifity and increased the yield 
of the desired products [26]. 
Like ELISA, PCR has a wide range of applications, including, among others, the 
measurement of somatic rearrangements and transcriptional switches of selected genes, 
studies of gene polymorphisms and the variability of gene expression. In addition to 
studying DNA, PCR can be 
extended by reverse transcription 
(RT) in order to detect specific 
strands of mRNA. This 
combination, which was first 
performed by Rappolee et al. in 
1989 [27], has greatly widened the 
spectrum of applications for PCR 
and is particularly useful when the 
clinical specimen are small or the 
number of cells is limited. 
RT makes use of reverse 
transcriptase, an enzyme found in 
RNA viruses which are capable to                         Fig. 2. [27a]             
synthesize cDNA from mRNA. The resulting cDNA mixture is then treated according to 
the PCR protocol described below using primers that are specific for the RNA to be 
detected. 
During PCR, DNA is amplified enzymatically. The first step simply entails mixing 
template DNA, two appropriate oligonucleotide primers, Taq DNA polymerase, 
deoxyribonucleoside triphosphates (dNTPs), and a buffer. Once assembled, the mixture is 
cycled a varying number of times ( section 8.2.2.) through temperatures that permit 
denaturation, annealing, and synthesis to exponentially amplify a product of specific size 
and sequence ( fig. 2). The PCR products are then displayed on an ethidiumbromide-
stained agarose gel to visualize the bands. 
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8.2.2. Details 
Total RNA was isolated from U-937 using Trizol-Reagent (GIBCO-BRL) as suggested 
by the manufacturer. After extraction by chloroform, precipitation by isopropanol, and a 
wash in 70% ethanol, RNA was dissolved in DEPC-treated water and stored at -70 
0C. 
Total RNA concentrations were determined using a Gene Quant (Pharmacia Biotech., 
Freiburg, Germany) photometric device. 500 ng of RNA were used for RT-PCR 
(GeneAmp RNA PCR kit, Perkin-Elmer Corp., Weiterstadt, Germany) according to the 
manufacturer´s instructions. Reverse transcription and PCR were performed on a 
thermocycler (Perkin Elmer Corp.). The protocols were as follows: RT: 42 
0C for 30 min, 
94 
0C for 5 min; PCR: 94 
0C for 1 min (1 cycle), followed immediately by 94 
0C for 1 min, 
60 
0C for 1 min, and 72 
0C for 2 min (with variable number of cycles) and a final extension 
phase at 72 
0C for 7 min. To investigate IL-8 mRNA expression the number of cycles was 
27. For MIP-130 cyclesand for glyceraldehydphosphate dehydrogenase (GAPDH) 25 
cycles were used. The sequences of the primers were as follows: IL-8 (F): 5´-ATg AcT Tcc 
AAg cTg gcc gTg gcT-3´; IL-8 (R): 5´-TcT cAg ccc TcT TcA AAA cTT cTc-3´ [28]; MIP-
1 (F): 5´-cgc cTg cTg cTT cAg cTA cAc-3´; MIP-1 (R): 5´-TgT ggA ggT cAc Acg cAT 
gTT-3´ [23]; GAPDH (F): 5´-Acc AcA gTc cAT gcc ATc Ac-3´; GAPDH (R): 5´-Tcc Acc 
Acc cTg TTg cTg TA-3´ [28]. PCR products were run on a 2% agarose gel containing 0.5 
g/ml ethidium bromide. Length of the amplicons were 452 bp, 289 bp, and 281 bp for 
GAPDH, IL-8, and MIP-1, respectively. 
 
8.2.3. Establishing an RT-PCR to detect Fas-Ligand 
One prominent signaling pathway associated with programmed cell death is the Fas / 
Fas-Ligand system. Studies have shown that the expression of FasL is upregulated during 
the process of apoptosis induced by TNF- and cAMP in PBMC. In order to detect FasL 
mRNA, I established an RT-PCR, using MgCl2 concentrations, the duration of the cycle 
stages (holds, denaturation, annealing, and synthesis), as well as the number of cycles as 
variables. Primers were self-designed following these guidelines: gc-content >40% for 
strong annealing, melting temperatures (Tm) >59 
0C and not more than 3 
0C apart, no base 
repetitions of more than three, no internal loops, no complementary sequences longer than 
two bp, at 3´-ends last two bases only g or c (for stronger annealing at the site of initiation 
of synthesis), and finally no other good match in the genome as determined by BLAST 
search. Note that not all of these criteria can always be met. Primers were synthesized by 
Gibco BRL. While RT was performed as described in the previous section, I used the  
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improved hot start TaqGold DNA polymerase (Perkin Elmer Corp.) to avoid unspecific 
results. As opposed to the AmpliTaq enzyme I previously used, hot start TaqGold 
polymerase is activated only by a 10 min incubation at 94 
0C, thus preventing premature 
DNA synthesis. The protocol listed below yielded a specific band ( fig. 3) with the length 
of the FasL mRNA (XX350 bp). This band was cut out of the gel, sequenced ( section 
8.4.) and identified as the correct fragment using BLAST search. 
 
 
Fig. 3. Establishment of the RT-PCR to detect FasL mRNA. 
PBMC were incubated for 16 h with 250  M cAMP. The 
number of PCR cycles is indicated. 
 
 
 
The following protocol was performed using a thermocycler (Perkin Elmer Corp.): 94 
0C for 10 mins (1 cycle), followed immediately by 94 
0C for 1 min, 56 
0C for 1 min, and 72 
0C for 2 min (30 cycles) and a final extension phase at 72 
0C for 7 min. A MgCl2 
concentration of 1.3 mM proved optimal. The sequences of the primers were as follows: 
FasL (F): 5´-ggA TTg ggc cTg ggg ATg TTT cA-3´; FasL (R): 5´-TTg Tgg cTc Agg ggc 
Agg TTg TTg-3´. Visualization was performed as described in section 8.2.1.  
 
 
8.3. Sequencing 
DNA sequencing was performed using the ABI-Prism 310 Genetic Analyser (PE 
Biosystems) based on the dideoxynucleotide chain termination method. In the termination 
labeling mix, the four dideoxy terminators (ddNTPs) are tagged with fluorescent dyes. This 
technique permits the simultaneous sequencing of all four reactions (A, C, G, and T) in one 
reaction tube. The probes are separated electrophoretically using a micro capillary. As each 
dye terminator emits light at a different wavelength when excited by laser light, all four 
colours corresponding to the four nucleotides can be detected and distinguished within a 
single run. Raw data were evaluated by the ABI-Prism sequencing analysis software. The 
sequencing reaction, as listed in the table, was performed in a thermocycler (GeneAmp 
2400, PE Biosystems) with 25 cycles of the following temperature steps: 96 °C for 10 s, 55 
°C for 5 s, and 60 °C for 2 mins. For the detection process, probes were prepared according  
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to manufacturer´s instructions. The mix was constructed as follows: 1 l of DNA (50 ng 
PCR derived DNA), 2 l of sequencing premix, 1 l of primer solution, and 6 l H2O.   
 
 
Fig. 4. Result of the sequencing procedure of the PCR amplicon of the FasL RT-PCR. 
 
 
8.4. Determination of Cell Viability 
Viable cells were quantified by measuring the amount of soluble formazan produced by 
cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS) according to the manufacturer´s instructions. After the 
indicated time periods under various experimental conditions, cells were resuspended and a 
20 l sample was removed and diluted in 200 l. The 220 l samples were put onto a 96-
well plate. 20 l of CellTiter 96
@AQueus One solution-MTS Reagent (Promega, Mannheim, 
Germany) were added to each well. After 1h at 37 
0C, absorbance was measured at 490 nm. 
Various cell numbers were used to ascertain the linearity of the assay. 
 
 
8.5. Electrophoresis Mobility Shift Assay 
8.5.1. Principles 
The mobility shift DNA-binding assay using gel electrophoresis (EMSA) was designed 
to either investigate the presence of transcription factors bound to nuclear DNA, or to find 
regulating sequences (promoters) of genes. A knowledge of the cellular content of these 
regulatory structures is valuable, since important processes, e.g. the development of an 
adult organism from a fertilized ovum or the maintenance of biochemical characterisitcs of 
the developed tissue, are known to be dependent on their presence.  
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Promoters are usually located upstream from the genes the expression of which they 
influence, and can be identified by their capability to bind transcription factors. If a protein 
binds to a DNA fragment, the molar mass of the newly formed complex is considerably 
higher than that of the DNA molecule alone. The presence or absence of the regulator can 
then be visualized by gel electrophoresis, as migration of the larger complex is retarded ( 
fig. 5). 
The transcription factors are 
located in the nucleus of a cell, thus 
the first step of the EMSA protocol 
is to create unfractioned protein-
extracts from the nuclei. Before 
these extracts can be mixed with 
DNA containing the regulating 
sequence, the DNA has to be 
incubated with a restriction endo-
nuclease which cleaves the long 
molecule into smaller fragments. 
With the appropriate experimental 
design it is now possible to detect 
the presence of a certain trans-
cription factor, e.g., as in our case, 
NF-B. If, however, the position of 
the regulating sequence is to be 
determined, this can be accomp-
lished with a restriction map.                                                          Fig. 5. [28a] 
 
8.5.2. Details 
Nuclear extraction was performed as follows: After washing the culture plate first with 
PBS, then with 0.1 mM EDTA in PBS the cells were transferred to Eppendorff cups and 
pelleted by centrifugation (2 min at 6000 rpm). The supernatant was completely removed 
and the pellet resuspended in 300 l cold hypotonic homogenisation buffer (10 mM 
HEPES pH 7.9, 10 mM KCl, 0.1 mM ethylene diamine tetraacetic acid (EDTA), 0.1 mM 
EGTA, 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulphonyl fluoride (PMSF)). 
After homogenisation, the resulting solution was allowed to swell on ice for 1 or 2 h, after  
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which 20 l of 10% Nonidet P-40 (NP40) was added, resulting in a final concentration of 
0.6%. This mix was vortexed, centrifuged for 1 min at 14 000 rpm, and resuspended in     
70 l ice-cold nuclear extract buffer (25% glycerol, 20 mM HEPES pH 7.9, 0.4 M NaCl,   
1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF). This solution was put on a shaker 
at full speed in the cold room for 20 min and again centrifuged for 5 min at 4 °C and        
13 000 rpm. 1 l of the resulting supernatant containing the desired nuclear extract was 
used to determine the protein content (Bio Rad). The rest was either used directly for the 
EMSA reaction or was stored at -70 °C.  
The EMSA procedure was begun with radioactive labeling of the complementary DNA 
strands with T4 polynucleotide kinase using [-
32P]ATP (3000 Ci/mmol). DNA-protein 
binding reactions were performed for 30 min on ice in a mixture (20 l) of 4% Ficoll,      
20 mM HEPES pH 7.9, 50 mM KCl, 1 mM EDTA, 1 mM DTT, 1mM PMSF, 0.25 mg/ml 
bovine serum albumin (BSA), 2 g of poly [dI-dC], and 20 000 dpm of 
32P-labeled 
oligonucleotides. Sequences of oligonucleotides were as follows: NF-B: 5´-ccc tac tgg 
gga ctc tcc ctt t-3´. DNA-protein complexes were separated from free DNA probe by 
electrophoresis through native 4.0% polyacrylamide gels at 40 mA in 0.5x Tris borate-
EDTA. Gels were fixed in 10% acetic acid and 10% isopropanol. After vacuum drying, the 
gels were exposed to Kodak X-Omat XAR film at -80 °C for 12-48 h.  
 
 
 
9. Statistics 
For experiments using U-937 cells and PBMC/whole blood cultures, data are shown as 
mean  SD or mean  SEM, respectively. Data are presented either as OD
405/495 nm, pg/ml, 
ng/ml, or as percent change compared to unstimulated control (100%) and were analyzed 
by unpaired Student´s t test (U-937 cells) or paired Student´s t test (PBMC, whole blood 
cultures) on raw data using Sigma Plot (Jandel Scientific). 
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10. Testing the Systems: Induction of IL-8 and MIP-1 
Expression in U-937 Cells and PBMC by TNF-, IL-1, and LPS 
and its Modulation by IL-10 and cAMP 
In order to verify my results, the experimental systems, procedures, and substances had to 
be tested for validity; e.g. reproducibility of procedures, stable dose-response relations of 
cellular responses, sensitivity of cells to modulating agents, and others. To accomplish this, I 
selected well-documented stimuli and modulators of IL-8 and/or MIP-1 expression and 
reproduced previous findings.  
 
 
10.1. U-937 
10.1.1. Dose-Response Relation of IL-8 and MIP-1 mRNA Synthesis and Protein Release 
after Stimulation with TNF-  
 
 
 
 
Fig. 1. TNF-  dose-dependently induces IL-8 
expression. U-937 cells were incubated for 19 h 
with  the  indicated  concentrations  of              
TNF-Release of IL-8 (A) and MIP-1 (B) 
protein was analyzed by ELISA, mRNA was 
assessed by RT-PCR (C). One representative RT-
PCR of three  independent experiments is 
shown. IL-8 protein quantities are presented as 
absolute IL-8 concentrations (C, figures on top).  
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TNF- is a prominent pro-inflammatory cytokine. It was among the earliest proteins of 
this family to be investigated thoroughly for structure and functions. Today it is known to 
exert a wide range of actions, among others the induction of multiple cytokines, including  
IL-8 and MIP-1. Therefore, TNF- is an ideal molecule to serve as stimulus when the 
validity of a system is to be tested. As expected, coincubation with TNF- dose-dependently 
upregulated IL-8 gene expression and protein release (fig. 1). 
 
 
10.2. PBMC 
10.2.1. Induction of IL-8 and MIP-1 Expression by TNF-and LPS 
As in U-937 cells, TNF- is a potent stimulator of pro-inflammatory actions also in 
PBMC. Lipopolysaccharides (LPS or endotoxin) are the surface molecules of gram-negative 
bacteria which cause the responses of the immune system to these microorganisms. If present 
at high concentrations, LPS eventually overwhelms host defense mechanisms and septic 
(endotoxic) shock ensues. Thus, endotoxin constitutes another inducer of the pro-
inflammatory chemokines IL-8 and MIP-1 as demonstrated in fig. 2. 
 
10.2.2. Modulation of inflammatory cytokine mRNA and Protein Levels by IL-10 and cAMP 
The prototype role which IL-1 and TNF- play in the family of the pro-inflammatory 
cytokines is taken by IL-10 in the anti-inflammatory field. By potently suppressing 
inflammatory cytokine production, IL-10 attenuates the potentially harmful fire of 
inflammation. That is what makes this molecule one of the most important regulators in the 
delicate equilibrium of the cytokine concert.  
Although reports on regulatory roles of the cyclic AMP signaling system on cytokine 
production are not entirely uniform, potent inhibition of TNF- production in human M, as 
well as upregulation of IL-10 and TGF-2 expression suggest that this pathway may 
represent a principle of M-deactivation. Therefore, I chose to verify cAMP as an inhibitor 
of the LPS-induced cytokine response. As shown in fig. 2, dibutyryl-cAMP (a synthetic 
analog to cAMP with increased stability and slow-release properties) potently suppresses 
TNF- as well as MIP-1 production in PBMC. Release of IL-8 was partially reduced by 
dBcAMP. 
 
 
  
48
 
 
 
 
 
Fig. 2. (A-G) LPS induces release of IL-8, MIP-1, and TNF-; the responses can be reduced by 
coincubation with cAMP. (H) TNF- stimulates IL-8 secretion which can be inhibited by IL-10. PBMC 
from two donors (JR, MN) were incubated for 19 h (A-G) with 10 ng/ml LPS in the presence or 
absence of (A-F) 250 M cAMP or (G) with 10 ng/ml IL-10. (H) PBMC were stimulated with 5 nM 
TNF- either toghether with or without 10 ng/ml IL-10. Release of IL-8 and TNF- protein were 
analyzed by ELISA. Data are expressed as absolute cytokine concentrations. 
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10.3. Whole Blood Culture 
10.3.1. IL-8 Expression is induced by IL-1 and can be inhibited by IL-10 
IL-1 shares a variety of properties with TNF- and was used to induce IL-8 release in 
WBC, our experimental model representing the microenvironment of the blood compartment. 
The anti-inflammatory actions of IL-10 are the subject of advanced studies with clinical 
relevance, e.g. in the fields of inflammatory bowel disease and rheumatoid arthritis [30, 31]. 
It has extensively been show that, in its role as a Th1 inhibitor, IL-10 potently suppresses 
chemokine release from immunocompetent cells. Also in my experiments IL-10 strongly 
reduced IL-1-stimulated IL-8 release from the blood cells of all donors investigated (fig.3).  
 
 
Fig. 3. IL-1 induces IL-8 release which can be 
inhibited by IL-10. WBC from 11 different donors 
were incubated for 24 h with 2nM IL-1  in the 
presence or absence of 10 ng/ml IL-10. Release of 
IL-8 was determined by ELISA. Data are 
expressed as absolute IL-8 concentrations.  
  
 
 
 
 
 
 
 
11. Expression of Chemokines is induced by VP-16 and is 
associated with apoptotic Cell Death in U-937 Cells. 
Exposure to oxygen radicals, NO, and other stressors  causes  chemokine  secretion  in       
U-937 cells. One of the hypotheses presented in this work is that this reaction can also be 
induced when stress is inflicted on cells by cytotoxic substances. Section 11.1. presents data 
showing that VP-16 is a potent inducer of apoptosis in my U-937 system; section 11.2. 
demonstrates the accompanying expression of chemokines. 
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11.1. Incubation with VP-16 causes apoptotic Cell Death in U-937 Cells 
I chose the DNA topoisomerase II inhibitor VP-16 as cytotoxic agent in the U-937 
system, because the compound is a well characterized inducer of apoptosis in these cells [32-
34]. Induction of apoptosis with accompanying DNA fragmentation was observed by gel-
electrophoresis after 6 h of exposure to VP-16 (3.1 g/ml) (fig. 4). Fig. 5 shows that ongoing 
apoptotic cell death was evident 6 h and 8 h (A) as well as 19 h (B) after onset of incubation 
with VP-16. A stringent dose-response curve was observed (B). At the late 19 h time point 
viability, as determined by the MTS-assay, was 36.7%  7.5%, 42%  8.1%, and 28.1%  
6.9% for VP-16 at 3.1 g/ml, 6.3 g/ml, and 12.5 g/ml, respectively (control set at 100%,   
n = 4). After 19 h of exposure to these concentrations of VP-16 and consistent with previous 
data [34], the majority of the remaining cells showed morphological signs of apoptosis as 
examined by light microscopy (data not shown).  
 
 
 
 
 
 
Fig. 4. VP-16 induces apoptotic fragmentation 
of DNA, TPCK inhibits this process. U-937 cells 
were incubated for 6 h with 3.1 g/ml VP-16 in 
the presence or absence of 50 M TPCK. DNA 
fragmentation was visulized by gel-
electrophoresis. 
 
 
 
 
 
 
Fig. 5. VP-16 induces apoptosis. U-937 cells were incubated for 6 h and 8 h with 6.3 g/ml VP-16 (A) 
or for 19 h with the indicated concentrations of VP-16 (B). Apoptosis was analyzed by ELISA. Mean 
DNA fragmentation (enrichment factor)  SD (n=3) are shown. **: p < 0.001 compared to control.   
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11.2. VP-16 promotes Synthesis and Release of IL-8 and MIP-1 in U-937 Cells 
In parallel with induction of apoptosis, VP-16 significantly increased protein release of 
IL-8 and MIP-1 (fig. 6A & B). The threshold concentration for VP-16-induced apoptosis as 
well as chemokine release was 1.56 g/ml for both responses (fig. 6). The lower 
concentration tested (0.16 g/ml) did neither induce apoptosis nor chemokine secretion. As 
expected, VP-16 also upregulated expression of IL-8 and MIP-1 mRNA which could be 
detected in the viable cell fraction after 19 h of exposure to VP-16 (fig. 6C).  
 
 
Fig. 6. VP-16 induces release of IL-8 and MIP-1U-937 
cells were incubated for 19 h with the indicated 
concentrations of VP-16 and MIP-1. Release of IL-8 and 
MIP-1 protein (A & B) were analyzed by ELISA, mRNA 
(C) was investigated by RT-PCR. (A) Data are expressed 
as percent change compared to control. Mean percent 
change in IL-8    SD (n=6) are shown. **: p < 0.01 
compared to control. (B) Data are presented as mean     
MIP-1 concentrations  SD (n=4). **: p < 0.01 compared 
to control. (C) One representative RT-PCR of three 
independent experiments is shown. Figures on top 
indicate absolute IL-8 protein quantities. 
 
 
The kinetics of VP-16 (6.3 g/ml)-induced chemokine mRNA expression and protein 
release revealed induction of mRNA for IL-8 and MIP-1 after 4 h of incubation. At this 4 h 
time point, no reduction of cell viability was detectable (96.3%  9.8% versus control set at 
100%, n = 3, MTS assay). First significant release of IL-8 protein induced by VP-16 was 
measurable after 6 h of treatment with VP-16 (226.5  53.8% compared to control, p < 0.05, 
n = 3, fig. 7A). Induction of apoptosis corresponded to release of IL-8, regarding both the 
kinetics and the dose-response relationship. VP-16-induced MIP-1protein release exhibited  
52
a similar dose-response relationship as observed for IL-8 release and induction of apoptosis 
(fig. 7C & D). However, the amount of protein was considerably lower compared to IL-8 and 
the kinetics of MIP-1 release appeared to be delayed, which is in accordance with previous 
studies with LPS-stimulated adherent PBMC [23].  
 
 
 
 
 
 
 
 
 
Fig. 7. Kinetics of VP-16-induced IL-8 and MIP-1 expression. (A & C) U-937 cells as unstimulated 
control (o) or exposed to 6.25 g/ml VP-16 () were incubated for the indicated time periods. 
Supernatants were assayed for IL-8 (A, insert) or MIP-1 (C) by ELISA. The results of one 
representative kinetics experiment out of three independently performed are shown. Data are 
expressed as absolute IL-8 or MIP-1 concentrations (A & C) or as mean percent change in IL-8  SD 
(n=3). *: p < 0.05 compared to control (insert). (B & D) Kinetics of VP-16-induced IL-8 and MIP-1 
mRNA expression of the same experiment were evaluated by RT-PCR. 
 
After a 19 h incubation period I was still able to detect cells which stained positive for 
MIP-1antigen. In unstimulated U-937 cells no cells positive for MIP-1 could be identified 
(fig. 8). Compared to VP-16 as a stimulus, incubation of U-937 cells with TNF- (45 ng/ml, 
19 h incubation) resulted in release of MIP-1 in a similar concentration range (597 pg/ml   
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Fig. 8. VP-16 induces expression of MIP-1. U-937 cells were incubated for 19 h with vehicle or           
6.25  g/ml VP-16. Expression of MIP-1 protein was evaluated by immunohistochemistry. This 
experiment was performed by Dr. Stefan Frank and Dr. Heiko Kämpfer and is displayed with their 
friendly permission. 
 
160 pg/ml versus 5 pg/ml  9 pg/ml for TNF- stimulation versus control, n = 6, p  0.01). 
Release of TNF- remained rarely detectable at all time points investigated (6 h, 8 h, 19 h) in 
U-937 cells exposed to 6.25 g/ml VP-16 and was below 10 pg/ml in all culture supernatants 
examined. Chemokine production by U-937 cells in our studies was not likely the result of 
release of preformed chemokines for two reasons: First, induction of apoptosis and release of 
chemokines was accompanied by early induction of expression of chemokine mRNA (fig. 7). 
Second, apoptosis of U-937 cells achieved by high concentrations of DMSO (4%) [35] was 
not associated with enhanced release of IL-8 (data not shown). 
 
Both IL-8 and MIP-1 are NF-B-dependent genes. Therefore, I investigated the degree of 
NF-B activation in U-937 cells exposed to VP-16. Fig. 9 shows an upregulated binding 
activity of the transcription factor. 
 
 
Fig. 9. Transcription factor NF-B is 
activated when U-937 cells are 
exposed to VP-16. U-937 cells were 
incubated for the indicated times with 
3.1 g/ml VP-16. Binding of NF-B to 
its consensus DNA-binding element 
was evaluated by EMSA.  
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12. Modulation of VP-16-induced Chemokine Expression and 
Apoptosis in U-937 Cells 
To further investigate signal transduction pathways by which VP-16-induced apoptosis 
and chemokine expression are mediated, I examined the effects of the following modulators 
of cellular responses: 
 
12.1. Serine Protease Inhibitor N
-tosyl-L-phenylalanine-chloromethyl ketone (TPCK) 
Previous studies have identified TPCK as a potent inhibitor of VP-16-induced apoptosis 
in U-937 cells [32]. Figs. 4 and 10B demonstrate that TPCK protected the cells from 
induction of apoptosis (no detectable DNA fragmentation in fig. 4, strong reduction of the 
quantitiy of free histones, fig. 10B). Interestingly, also release of IL-8 protein was prevented 
when TPCK was added (fig. 10A).  
 
Fig. 10. Modulation of VP-16-induced IL-8 release or apoptosis by TPCK. U-937 cells were incubated 
for 19 h with 3.1 g/ml VP-16 with or without 50 M TPCK. Release of IL-8 (A) and apoptosis (B) 
were determined by ELISA. IL-8 release is expressed as percent change compared to control. Mean 
percent changes in IL-8  SD (n=4) are shown. **: p < 0.01 compared to control; ##: p < 0.01 compared 
to VP-16 alone and not significantly different from control. Apoptosis is quantified as mean DNA 
fragmentation (enrichment factor)  SD (n=3), **: p < 0.01 compared to control; ##: p < 0.01 compared 
to VP-16 alone and not significantly different from control. 
 
 
 
12.2. p38 Mitogen Activated Protein Kinase (MAP-Kinase) Inhibitor SB203580 
Activation of p38 MAP-kinases holds a central position in signal transduction pathways 
which regulate cytokine production in response to inflammatory stimuli or stress ( section 
3.1.). In accordance with this concept, SB203580 inhibited release of IL-8 after exposure to 
VP-16 (fig. 11A). Interestingly, the apoptotic process remained unaffected (fig. 11B).  
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Fig. 11. Modulation of VP-16-induced IL-8 release or apoptosis by SB203580. U-937 cells were 
incubated for 19 h with 3.1 g/ml VP-16 in the presence or absence of the indicated concentrations of 
SB203580 (A) or with 0.3 M SB203580 (B). Release of IL-8 (A) and apoptosis (B) were determined by 
ELISA. IL-8 release is expressed as percent change compared to control. Mean percent changes in IL-8 
 SD (n=6) are shown. **: p < 0.01 compared to control; ##: p < 0.01 compared to VP-16 alone and not 
significantly different from control; #: p < 0.05 compared to VP-16 alone. Apoptosis is quantified as 
mean DNA fragmentation (enrichment factor)  SD (n=3), **:  p  <  0.01  compared  to  control;               
##: p < 0.01 compared to VP-16 alone and not significantly different from control. 
 
 
 
 
12.3. Transforming Growth Factor  
TGF- is a versatile molecule which is often acutely modulated in response to a variety of 
stress and disease signals. It influences many aspects of the immune response. TGF- 
mediates antiinflammatory responses via suppression of inflammatory cytokine synthesis. In 
our experiments, TGF- had effects similar to SB203580, as it inhibited VP-16-induced   
IL-8 release (fig. 12), but did not interfere with apoptosis (data not shown). 
 
 
Fig. 12. Modulation of VP-16-induced IL-8 release by 
TGF-1. U-937 cells were incubated for 19 h with the 
indicated concentrations of VP-16 and/or TGF-
Release of IL-8 was determined by ELISA.  IL-8 
release is expressed as percent change compared to 
control. Mean percent changes in IL-8  SD (n=4) are 
shown. **: p < 0.01 compared to control; *: p < 0.05 
compared to control; ##: p < 0.01 compared to VP-16 
alone; #: p < 0.05 compared to VP-16 alone. 
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13. Determination of IL-8 mRNA Half-Life 
Along with increased synthesis and release of proteins, modulation of the half-lives of 
their respective mRNAs is another concept in cytokine biology that is utilized to promote the 
efficacy of immune responses. Therefore, I determined the half-life of VP-16-induced IL-8 
mRNA. 
As shown in fig. 13, VP-16-induced IL-8 mRNA is degraded with a half-life of 4.6 h. 
Background expression of IL-8 was too low in these cells to be determined by RT-PCR with 
the necessary accuracy. Thus I could not determine the half-life of background IL-8 mRNA 
in these experiments. However, in a previous study this background half-life was determined 
to be 0.6 h [36]. Although additional experiments are necessary to verify these findings, it 
appears that, besides NF-B activation, mRNA stabilisation may contribute to VP-16-
induced increase of IL-8 protein levels in U-937 cells. 
 
 
 
Fig. 13. Determination of IL-8 mRNA half-life in U-937 
cells coincubated with 3.1 g/ml VP-16. Cells were 
treated with VP-16 for 6.5 h. Thereafter, transcription of 
additional IL-8 mRNA was blocked using actinomycin 
D which was added at time point 0 h.  
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14. 2-Chlorodeoxyadenosine (CdA) enhances IL-8 and TNF- 
Release from PBMC in parallel to strong Induction of Apoptotic 
Cell Death. 
Recently, it has been reported that CdA efficiently induces apoptosis after a 24 h 
incubation period in resting PBMC [37]. I confirmed these findings in adherent PBMC after 
exposure to CdA (fig. 14A). In parallel, I observed augmented release of IL-8 from the same 
set of cells (fig. 14B), as well as in whole blood cultures (WBC) (fig. 14E). The amounts of 
IL-8 released from adherent PBMC were always higher than those secreted from WBC; this 
is most likely due to inevitable activation of monocytes during isolation and cultivation of 
adherent PBMC. In six out of the eight PBMC donors, I detected induction of TNF- release 
(fig. 14C). Fig. 14D shows a correlation analysis comparing TNF- and IL-8 protein levels; 
IL-8 release correlated significantly with release of TNF- (r = 0.86). Induction of IL-8 was 
evident in the presence of polymyxin B (PmxB; final concentration: 1 g/ml), which was 
routinely added to CdA and vehicle. At this concentration PmxB completely suppressed LPS 
(10 ng/ml)-induced release of IL-8 (24.1  7.9 ng/ml, 172.9  6.9 ng/ml, 29.1  9.4 ng/ml for 
PmxB alone, LPS, and LPS/PmxB, respectively, n = 3). In four out of the eight donors tested, 
the experiments were performed in the presence and absence of PmxB in controls and CdA 
stimulations. I did not observe a more dramatic enhancing effect of CdA on IL-8 release in 
the absence of PmxB (22.7  10.8 ng/ml versus 48.4  9.3 ng/ml for control and CdA in the 
absence of PmxB, n = 4, p  0.01; 15.6  7.2 ng/ml versus 40.4  7.8 ng/ml for control and 
CdA in the presence of PmxB, n = 4, p  0.01). From this I conclude that CdA-induced IL-8 
as well as TNF- release is not a result of a latent endotoxin contamination in the CdA 
preparation. When unstimulated PBMC were lysed after a 20 h incubation period by three 
cycles of freezing and thawing in culture supernatant, no significant difference in IL-8 
concentrations was observed between these whole cell lysates and the respective, equally 
treated, cell-free culture supernatant alone (112.4%  16% compared with cell-free 
supernatant only, set at 100%, n = 3). Thus, I conclude that CdA-induced IL-8 release from 
adherent PBMC is not a consequence of release of preformed IL-8. As shown in Fig. 14D, 
CdA was also active in inducing IL-8 release in whole blood cultures.  
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Fig. 14. CdA induces apoptosis as well as IL-8 and TNF- release from adherent PBMC and augments 
release of IL-8 from WBC. PBMC (A, B, and C) or WBC (E) were stimulated for 24 h with the 
indicated concentrations of CdA. Apoptotic cell death (A), release of IL-8 (B, E), and TNF- (C) were 
determined by ELISA. (A) Apoptosis is quantified as mean DNA fragmentation (enrichment factor)  
SEM (n=3), **: p < 0.01 compared to control. (B, C) Data are expressed as absolute cytokine 
concentrations. **: p < 0.01 compared to control. (D) Production of TNF- is plotted against IL-8. The 
correlation is significant at r = 0.86. (E) Data are expressed as mean IL-8 concentrations  SEM (n=9), 
**: p < 0.01 compared to control.  
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IV. Discussion I IV V. .   D Di is sc cu us ss si io on n     
 
Apoptosis is an active, organized strategy for safe removal of unwanted cells in 
multicellular organisms. This type of cell death is supposed to avoid the initiation of an 
inflammatory response before the dying cell disintegrates, which inevitably would lead to 
release of potentially hazardous cell constituents. The prevention of this spillage is 
accomplished by early phagocytosis [38].  
 
Since rapid phagocytosis plays an essential role in the pathophysiology of apoptosis as 
described above, efficient attraction of potent phagocytes is likely to be a critical parameter 
of the process. This is what renders chemokine expression during apoptotic cell death an 
interesting topic of investigation. I have shown that initiation of programmed cell death in 
the promonocytic cell line U-937 by the cytotoxic drug VP-16 is associated with expression 
and release of the chemokines IL-8 and MIP-1. Induction of mRNA for MIP-1 and IL-8 
was evident as early as 4 h after onset of stimulation with VP-16. IL-8 protein release was 
significantly augmented after 6 h of exposure to VP-16.  
 
In the present study, I do not address the molecular basis of VP-16-induced chemokine 
expression in further detail. However, in accordance with previous observations [34] I was 
able to detect activation of the transcription factor nuclear factor-B (NF-B) in U-937 
cells through VP-16. As NF-B is an important mediator in the signaling pathway of IL-8 
induction, these results provide a link between VP-16-induced cellular stress and 
expression of IL-8 and other NF-B-dependent genes. 
 
I determined the half life of VP-16-induced IL-8 mRNA to be 4.6 hours, which is 
relatively high compared to the previously reported background half life of 40 mins [36]. 
Although additional studies are necessary, these results suggest that VP-16 may enhance 
the stability of IL-8 mRNA. Such an effect should contribute to upregulation of IL-8 
protein by VP-16. In this context it is worthwhile to note that IL-8 mRNA contains several 
AU-rich sequences in its 3´ untranslated region that have previously been shown to render 
mRNA transcripts more susceptible to degradation. In turn, these AU-rich sequences and 
proteins binding to them may be targeted by strategies aiming at an increase of IL-8 mRNA 
stability. 
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It is necessary to exclude the possibility that release of chemokines occurs due to 
secondary necrosis. When I performed MTS viability assays after a 4 h incubation period 
with 6.3 g/ml VP-16, I was not able to detect a significant decrease in staining and hence 
cell number, despite induction of IL-8 under these conditions. I can thus conclude that 
initiation of chemokine expression in our experiments is a rapid process and not likely due 
to secondary necrosis. I furthermore infer that induction of chemokine expression is 
compatible with apoptotic death in these cell cultures. Parallel experiments with the two 
NO-donors (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)-amino]diazen-1-ium-1,2-diolate 
(DETA-NO) and sodium nitroprusside revealed that the respective efficacy to induce IL-8 
in U-937 cells is linked to the capacity of each compound to induce apoptosis in these cells 
[11]. This observation provides further evidence for the close association of chemokine 
induction and apoptotic cell death in this experimental system.  
 
Cellular responses to various forms of stress are frequently mediated by activation of 
p38 MAP-kinases. These responses include release of cytokines, such as IL-1, TNF-[39], 
or IL-8 [28]. In agreement with this concept, inhibition of p38 MAP-kinases using the 
specific inhibitor SB203580 prevented IL-8 release in response to stress induced by the 
cytotoxic drug VP-16. However, SB203580 did not modulate VP-16-induced apoptosis. 
This observation corresponds with a recent study which reports that p38 MAP-kinases are 
not involved in apoptosis induced by UV irradiation in U-937 cells [40].  
 
TGF- is an important endogenous 
modulator of immune responses. [8] In 
our experiments, coincubation with 
TGF- inhibited VP-16-induced IL-8 
secretion, but, similar to SB203580, 
the apoptotic process remained 
unaffected.         Fig. 1  
          
In contrast to SB203580 and TGF-
, the serine protease inhibitor TPCK 
prevented both induction of apoptosis 
as well as IL-8 secretion. I assume that 
VP-16-induced IL-8 secretion and apoptosis share a proximal signaling pathway which is  
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dependent on the activity of a TPCK-sensitive serine protease. More downstream the 
pathways of IL-8 induction and apoptosis split. As a result, SB203580 and TGF- inhibit 
IL-8 release only ( fig. 1). I suggest that the pathways leading to chemokine upregulation 
and to apoptotic death evolve partially common and/or parallel and that both represent 
cellular reponses to stress. This concept is supported by recently published data which 
demonstrate that caspase inhibitors completely block apoptotic death induced by Fas-
associated pro-apoptotic stimuli in human smooth muscle cells, but only modestly 
decreased MCP-1 transcription. The authors conclude that the terminal events of the 
apoptotic signaling cascade initiated by Fas/FADD are not necessary for chemokine release 
[41].  
 
The experiments with the promonocytic cell line U-937 were complemented by studies 
using human PBMC and whole blood cultures. It has recently been demonstrated that 
incubation with CdA induces a strong apoptotic response in resting PBMC [37]. In addition 
to being able to confirm this response when I exposed adherent PBMC to CdA, I observed 
an accompanying amplification of baseline IL-8 production. Interestingly, I also detected 
TNF- protein release in these experiments. 
 
CdA significantly augmented release of IL-8 not only from PBMC, but also from human 
whole blood cultures. Although the molecular mechanisms underlying CdA-induced IL-8 
induction cannot be addressed thoroughly in this system, it is interesting to note that CdA is 
able to induce IL-8 in the physiological microenvironment of the blood compartment. This 
fact acquires further significance when one recalls that CdA is a chemotherapeutic drug 
which is administered intravenously for the treatment of different kinds of haematologic 
neoplastic diseases, such as hairy cell leukaemia or chronic lymphatic leukaemia, and a 
number of other malignancies. 
 
The next logical step in our series of experiments was to try an endogenous inducer of 
apoptosis to further generalize our statements. Our choice fell on the Fas – FasL system, for 
it does not only constitute an important mediator of programmed cell death, but also has 
special relevance for our experimental settings as it plays an essential role in 
immunological self-tolerance and homeostasis of the lymphocyte population. To elaborate 
whether FasL was expressed by U-937 cells and/or PBMC exposed to the cytotoxic agents 
VP-16 or CdA, respectively, and was then active as an inducer of apoptosis in an auto- and  
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paracrine manner, I established an RT-PCR to detect FasL mRNA. Furthermore, I 
stimulated U-937 cells with an activating monoclonal anti-Fas antibody and assayed the 
supernatants for chemokines. Unfortunately, these studies could not be completed as 
planned, as I detected a strong LPS contamination in the anti-Fas antibody.  
 
When apoptosis was defined, it was claimed that this form of cell death was 
antiinflammatory per se or at least occured strictly without inducing inflammation, since it 
was theorized to be a physiologic way of cells to die. This naturally implies a process that 
causes the smallest possible amount of disturbance to the surrounding cells, tissues, and 
organ systems. The present study is in disharmony with this concept: In addition to the fact 
that chemokines alone are capable of inducing local inflammatory responses, I observed 
release of TNF- a prototype of the pro-inflammatory cytokines, from adherent PBMC 
after incubation with quantities of CdA that also induced apoptosis. Moreover, protein 
levels of TNF- in the supernatants of these experiments correlated well with the respective 
IL-8 contents. These results imply that TNF- might play a role as mediator during the 
induction of IL-8 expression through CdA. 
 
In recent times the number of studies which support opposition to the anti-inflammatory 
concept of apoptosis has steadily been growing. For instance, FasL, a major endogenous 
activator of apoptotic cell death, has recently been implicated as a mediator of induction of 
inflammatory genes [42]. Corresponding to the present data, FasL is indeed able to trigger 
release of IL-8 in rheumatoid arthritis synoviocytes [43] as well as in bronchiolar epithelial 
cells [44]. It is also capable to induce inflammatory angiogenesis with leucocyte 
recruitment in vivo [45]. These reports provide evidence for a possible role of FasL as a link 
between apoptosis and chemokine release.  
Another prominent pro-inflammatory cytokine that has recently been associated with the 
execution of the apoptotic program is IL-1. It has been found that induction of apoptosis 
goes along with release of IL-1 in murine peritoneal exsudate cells [46]. Likewise, another 
study shows a close connection of the kinetics of apoptosis, phagocytosis, and the synthesis 
of IL-1 and IL-8. The authors found cytokine upregulation in primary macrophages and 
THP-1 cells cocultured with murine apoptotic CTLL-2 cells [47]. Furthermore, gene 
expression of the murine IL-8 homologue MIP-2 as well as of both IL-1 and IL-1 in 
murine peritoneal exudate cells was inducible by contact with apoptotic T-cells [45]. The 
coculture supernatants from these experiments were able to initiate accumulation of  
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neutrophils in vivo, thus proving that chemokines released in association with apoptotic cell 
death are biologically active.  
The following three studies provide further in vivo data, underscoring the physiological 
relevance of the pro-inflammatory aspects of apoptosis. Uchimura et al induced apoptosis 
of lymphoid organs in mice by whole-body X-ray irradiation. Apoptotic cell death was 
accompanied by transient upregulation of MIP-2 mRNA, as well as accumulation of 
neutrophils. Both processes peaked at 9 h and were significantly reduced when the 
experiment was performed in p53
-/- mutants which are resistant to radiation-induced 
apoptosis [48]. Another study reports similar effects in murine ischemia/reperfusion-injured 
kidneys. In addition to upregulation of MIP-2 and neutrophil influx, the authors also found 
functional impairment of the kidney. Interestingly, these effects could be abrogated by i.p. 
injection of a pan-caspase inhibitor, hinting at an important role of these enzymes in 
cytokine induction accompanying apoptosis [49]. Schaub et al [41] performed their 
experiments in injured vessel walls of carotid arteries of live rats. Besides recruitment of 
macrophages into the wounds, this report reveals further details about the mechanisms of 
chemokine release paralleling apoptosis: The upregulation of chemokines induced by Fas-
associated pro-apoptotic stimuli in human smooth muscle cells was significantly, but not 
completely, reduced by blockage of IL-1 activity. This emphasizes the role of IL-1as a 
mediator, but also provides evidence for an additional, IL-1-independent pathway for Fas 
induction of chemokine expression.  
The latter studies [41, 48, 49] obviously stand in contrast with reports showing 
deactivation of LPS-stimulated human macrophages after contact with apoptotic cells [50, 
8].  
When critically assessing these results, one should keep in mind that our study 
investigates the consequence of stress-induced apoptosis in the cytokine producer itself. 
This situation is definitely different from the experimental setting of the other studies 
presented above [45, 50, 8].  
Recently published reports furthermore supply data regarding cellular stress inflicted by 
chemotherapeutic drugs. In agreement with our results, Lee et al [51] state that the 
chemotherapeutic agent taxol can induce IL-8 in human ovarian cancer cells. Taxol is a 
microtubule-stabilizing agent which is antiproliferative and pro-apoptotic. IL-8 induction 
correlated with apoptosis in this system. Similarly, platinum compounds were shown to 
upregulate the protein levels of IL-8 and IL-1 in human umbilical vein endothelial cells 
[52]. Moreover, augmentation of IL-8 release was detected in human CD4
+ T-cells during  
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ongoing apoptotic cell death induced by crosslinking of CD2 and/or CD28 after antigen 
exposure and propagation with IL-2 [53]. 
 
Based on the published data and the results of the present study, I conclude that the 
presence of cellular stressors such as chemotherapeutic drugs initiates apoptosis in U-937 
cells, adherent PBMC, and WBC. This event is associated with expression of chemokines. I 
suggest that the resulting chemokine gradients serve to “tag” cells which have been 
irreparably damaged by the respective insult and which are about to undergo apoptosis, as 
targets for invading phagocytes. These processes may represent an advantageous strategy 
which contributes to efficient and safe removal of apoptotic cells.  
     
     
V. Summary V V. .   S Su um mm ma ar ry y     
Removal of apoptotic cells by macrophages or resident semi-professional phagocytes is 
a prominent principle with important implications for the pathophysiology of chronic 
inflammatory diseases, viral infections, or cancer. To characterize mechanisms which may 
determine the fate of apoptotic cells, I investigated chemokine expression in apoptotic 
promonocytic U-937 cells or PBMC. Exposure of U-937 cells to the anti-cancer drug 
etoposide (VP-16), an inducer of apoptosis in these cells, was associated with increased 
expression of the chemokines IL-8 and macrophage inflammatory protein 1 (MIP-1). 
Upregulation of IL-8 mRNA expression by VP-16 was observed as early as 4 h after onset 
of treatment and was still detectable after 19h of exposure. A serine protease inhibitor 
prevented both VP-16-induced apoptosis and release of IL-8, whereas inhibition of p38 
MAP-kinases reduced IL-8 secretion only. Moreover, I observed that  incubation  with        
2-chlorodeoxyadenosine (CdA) upregulated release of IL-8 from adherent PBMC in 
parallel to induction of apoptosis. In these cells a modest but significant induction of       
TNF- release by CdA was also detected. In addition, CdA augmented release of IL-8 from 
whole blood cultures. By facilitating adequate recruitment of phagocytes to sites of cell 
death, stress-induced upregulation of chemokines associated with apoptosis may contribute 
to mechanisms aiming at efficient removal of apoptotic cells.   
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VII. Zusammenfassung V VI II I. .   Z Zu us sa am mm me en nf fa as ss su un ng g     
 
Das Abräumen apoptotischer Zellen durch Makrophagen oder ortsgebundene 
Gewebsphagozyten ist ein wichtiger Prozeß, dessen Ablauf die Pathophysiologie von 
verschiedenen Krankheitsbildern entscheidend beeinflussen kann. Dazu zählen unter anderem 
chronisch entzündliche Erkrankungen, Virusinfektionen und Neoplasien. Zur 
Charakterisierung dieser Vorgänge untersuchte ich die Chemokinfreisetzung in apoptotischen 
promonozytischen U-937 Zellen und mononukleären Zellen aus peripherem Venenblut 
(PBMC). In der Zellinie konnte ich zeigen, daß die Expression der Chemokine Interleukin 8 
(IL-8) und Macrophage Inflammatory Protein 1 (MIP-1) durch das in diesen Zellen 
Apoptose induzierende antineoplastische Medikament Etoposid (VP-16) hochreguliert wird. 
Diese Steigerung der mRNA-Expression war bereits 4 Stunden nach Beginn des Experiments 
nachweisbar und blieb bis zum 19 Stunden-Zeitpunkt erhalten. Durch Zugabe eines Serin 
Protease Inhibitors waren sowohl die VP-16-induzierte Apoptose als auch die IL-8 
Freisetzung hemmbar, während ein p38 MAP-Kinase Inhibitor nur die IL-8 Sekretion 
beeinträchtigte.  
Desweiteren  zeigten  meine  Studien,  daß  in  adhärenten  PBMC,  in  denen  ich  mit                 
2-Chlorodeoxyadenosin (CdA) Apoptose induzierte, die IL-8 mRNA Expression und 
Proteinproduktion mit dem Zelltod einhergingen. Unter diesen Bedingungen konnte ich 
außerdem eine signifikante Hochregulation der TNF- Produktion feststellen. Auch in der 
Vollblutkultur induzierte CdA IL-8. 
Die durch Zellstreß hervorgerufene Hochregulation von Chemokin-mRNA und Protein ist 
demnach eng mit dem parallel ablaufenden programmierten Zelltod assoziiert. Dies 
impliziert, daß die situationsgerechte Rekrutierung von Phagozyten an Orte, an denen 
Apoptose stattfindet, einen wichtigen Mechanismus zur Beseitigung sterbender Zellen 
darstellt. 
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